Corix Bioscience (CXBS) 10-Q 20 Nov 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 20, 2017
Document And Entity Information
Entity Registrant Name	CORIX BIOSCIENCE, INC.
Entity Central Index Key	1,433,821
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,865,408
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Successor [Member]
ASSETS
Cash	$ 360,871
Prepaid expense and deposits	890,629
Inventory	45,000
Assets held for discontinued operations	120,768
Total Current Assets	1,417,268
Equipment	82,388
Intangible asset	250,000
Assets held for discontinued operations	2,594,107
Total Assets	4,343,763
Current Liabilities
Accounts payable and accrued liabilities	25,678
Due to related parties	10,000
Convertible notes, net of discount of $283,886	50,026
Liabilities held for discontinued operations	47,197
Total Current Liabilities	132,901
Liabilities held for discontinued operations	652,836
Total Liabilities	785,737
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding	0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)	206,531
Additional paid-in capital	8,650,031
Accumulated deficit	(5,298,536)
Total Corix Bioscience, Inc.'s Shareholders' Equity	3,558,026
Non-controlling interest	0
Total Shareholders' Equity	3,558,026
Total Liabilities and Shareholders' Equity	4,343,763
Predecessor [Member]
ASSETS
Cash		$ 2,151
Prepaid expense and deposits		24,125
Inventory		0
Assets held for discontinued operations		211,558
Total Current Assets		237,834
Equipment		4,592
Intangible asset		0
Assets held for discontinued operations		11,127,246
Total Assets		11,369,672
Current Liabilities
Accounts payable and accrued liabilities		65,788
Due to related parties		407,728
Convertible notes, net of discount of $283,886		0
Liabilities held for discontinued operations		600,466
Total Current Liabilities		1,073,982
Liabilities held for discontinued operations		4,690,077
Total Liabilities		5,764,059
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding		0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)		96,819
Additional paid-in capital		16,803,120
Accumulated deficit		(12,424,339)
Total Corix Bioscience, Inc.'s Shareholders' Equity		4,475,600
Non-controlling interest		1,130,013
Total Shareholders' Equity		5,605,613
Total Liabilities and Shareholders' Equity		11,369,672
Preferred Class A [Member] | Successor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding	$ 0
Preferred Class A [Member] | Predecessor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding		$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Successor [Member]
Preferred Stock, Shares Authorized	9,980,000
Preferred Stock, Par Value	$ 0.001
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Common Stock, Shares Authorized	500,000,000
Common Stock, Par Value	$ 0.01
Common Stock, Shares Issued	20,653,140
Common Stock, Shares Outstanding	20,653,140
Predecessor [Member]
Preferred Stock, Shares Authorized		9,980,000
Preferred Stock, Par Value		$ 0.001
Preferred Stock, Shares Issued		0
Preferred Stock, Shares Outstanding		0
Common Stock, Shares Authorized		500,000,000
Common Stock, Par Value		$ 0.01
Common Stock, Shares Issued		9,681,929
Common Stock, Shares Outstanding		9,681,929
Preferred Class A [Member] | Successor [Member]
Preferred Stock, Shares Authorized	20,000
Preferred Stock, Par Value	$ .001
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Preferred Class A [Member] | Predecessor [Member]
Preferred Stock, Shares Authorized		20,000
Preferred Stock, Par Value		$ 0.001
Preferred Stock, Shares Issued		0
Preferred Stock, Shares Outstanding		0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2017	Apr. 06, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Predecessor [Member]
Expenses
Depreciation		$ 1,279	$ 382		$ 382
General and administrative		63,322	327,173		904,096
Total expenses		(64,601)	(327,555)		(904,478)
Net loss before other income (expense) from continuing operations		(64,601)	(327,555)		(904,478)
Other income (expense)
Accretion		0	0		0
Interest expense		0	0		0
Loss from legal settlement		0	0		0
Net loss from continuing operations		(64,601)	(327,555)		(904,478)
Discontinued operations
Net loss from discontinued operations (Note 12)		(139,805)	(1,220,571)		(3,386,133)
Net loss		$ (204,406)	$ (1,548,126)		$ (4,290,611)
Basic and diluted loss per share:
Net loss per share attributable to common stockholders - continuing operations		$ (0.01)	$ (0.04)		$ (0.11)
Net loss per share attributable to common stockholders - discontinued operations		$ (0.01)	$ (0.14)		$ (0.41)
Weighted average shares outstanding - basic and diluted		9,739,390	8,844,605		8,206,447
Successor [Member]
Expenses
Depreciation	$ 2,094			$ 2,520
General and administrative	297,860			993,986
Total expenses	(299,954)			(996,506)
Net loss before other income (expense) from continuing operations	(299,954)			(996,506)
Other income (expense)
Accretion	(231,512)			(250,026)
Interest expense	(5,592)			(6,767)
Loss from legal settlement	18,486			(740,756)
Net loss from continuing operations	(518,572)			(1,994,055)
Discontinued operations
Net loss from discontinued operations (Note 12)	(2,621,571)			(3,304,481)
Net loss	$ (3,140,143)			$ (5,298,536)
Basic and diluted loss per share:
Net loss per share attributable to common stockholders - continuing operations	$ (0.03)			$ (0.10)
Net loss per share attributable to common stockholders - discontinued operations	$ (0.13)			$ (0.17)
Weighted average shares outstanding - basic and diluted	20,514,576			20,016,523

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended
	Sep. 30, 2017	Apr. 06, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Items not affecting cash:
Depreciation						$ 56,772	$ 109,260
Stock-based compensation							450,801
Predecessor [Member]
Cash Flows from Operating Activities
Net loss		$ (204,406)		$ (1,548,126)				$ (4,290,611)
Add net loss from discontinued operations		139,805						3,386,133
Items not affecting cash:
Depreciation		1,279	$ 43,269	382				382
Stock-based compensation		0						650,265
Accretion		0		0				0
Gain on forgiveness of debt		0						(8,088)
Loss on legal settlement		0						0
Changes in operating assets and liabilities:
Prepaid expenses and deposits		10,369						(2,005)
Accounts payable		0						0
Inventory		(4,068)						56,006
Accrued liabilities		44,399						51,050
Due to related parties		0						(21,202)
Net Cash Used in Operating Activities - Continuing Operations		(12,622)						(178,070)
Net Cash Provided by (Used in) Operating Activities - Discontinuing Operations		(255,214)	(255,214)					(1,322,309)
Net Cash Used In Operating Activities		(267,836)						(1,500,379)
Cash Flows from Investing Activities
Purchase of equipment		0						(5,116)
Purchase of licenses		0						0
Proceeds from sale of real estate properties in relation to legal settlement		0						0
Cash acquired from reverse merger		0						0
Net Cash Provided by Investing Activities - Continuing Operations		0						(5,116)
Net Cash Provided by Investing Activities - Discontinuing Operations		381,404	381,404					188,292
Net Cash Provided by Investing Activities		381,404						183,176
Cash Flows from Financing Activities
Proceeds from the sale of common stock		133,166						509,600
Proceeds from exercise of stock options		0						0
Cash paid for redemption of common stock		0						0
Proceeds from issuance of convertible debt, net of original debt discount		0						0
Debt financing costs		0						0
Repayment of convertible debt		0						0
Advance from related parties		0						425,774
Repayment of related party advances		(107,051)						0
Net Cash Provided by Financing Activities - Continuing Operations		26,115						935,374
Net Cash (Used in) Provided by Financing Activities - Discontinuing Operations		(21,427)	(21,427)					272,905
Net Cash Provided by Financing Activities		4,688						1,208,279
Change in Cash		118,256						(108,924)
Cash - Beginning of Period		2,151	$ 2,151		$ 120,407		2,151	199,570
Cash - End of Period		120,407		$ 90,646				90,646
Interest paid		68,902						216,815
Income taxes paid		0						0
Notes payable and amounts due to related party settled from sale of real properties		742,504						0
Related party note receivable from sale of real properties		0						0
Debt discount recorded for beneficial conversion features and relative fair value of warrant		0						0
Stock issued for acquisition of real properties		0						1,085,726
Note payable issued with acquisition of real properties		0						691,155
Related party notes payable issued with acquisition of real property		0						76,876
Issuance of limited partnership units in exchange for real estate properties		0						$ 1,130,014
Successor [Member]
Cash Flows from Operating Activities
Net loss	$ (3,140,143)				(5,298,536)
Add net loss from discontinued operations					3,304,481
Items not affecting cash:
Depreciation	2,094				2,520
Stock-based compensation					608,434
Accretion	231,512				250,026
Gain on forgiveness of debt					0
Loss on legal settlement					740,756
Changes in operating assets and liabilities:
Prepaid expenses and deposits					(876,873)
Accounts payable					(45,000)
Inventory					(36,513)
Accrued liabilities					(43,928)
Due to related parties					10,000
Net Cash Used in Operating Activities - Continuing Operations					(1,384,633)
Net Cash Provided by (Used in) Operating Activities - Discontinuing Operations					(1,131,266)	(1,131,266)
Net Cash Used In Operating Activities					(2,515,899)
Cash Flows from Investing Activities
Purchase of equipment					(81,595)
Purchase of licenses					(250,000)
Proceeds from sale of real estate properties in relation to legal settlement					1,024,695
Cash acquired from reverse merger					120,407
Net Cash Provided by Investing Activities - Continuing Operations					813,507
Net Cash Provided by Investing Activities - Discontinuing Operations					3,270,597	3,270,597
Net Cash Provided by Investing Activities					4,084,104
Cash Flows from Financing Activities
Proceeds from the sale of common stock					0
Proceeds from exercise of stock options					650
Cash paid for redemption of common stock					(155,896)
Proceeds from issuance of convertible debt, net of original debt discount					452,750
Debt financing costs					(14,750)
Repayment of convertible debt					(200,000)
Advance from related parties					0
Repayment of related party advances					0
Net Cash Provided by Financing Activities - Continuing Operations					82,754
Net Cash (Used in) Provided by Financing Activities - Discontinuing Operations					(1,290,088)	(1,290,088)
Net Cash Provided by Financing Activities					(1,207,334)
Change in Cash					360,871
Cash - Beginning of Period					0
Cash - End of Period	$ 360,871	$ 0			360,871	$ 360,871	$ 360,871
Interest paid					163,487
Income taxes paid					0
Notes payable and amounts due to related party settled from sale of real properties					2,379,444
Related party note receivable from sale of real properties					325,000
Debt discount recorded for beneficial conversion features and relative fair value of warrant					438,000
Stock issued for acquisition of real properties					0
Note payable issued with acquisition of real properties					0
Related party notes payable issued with acquisition of real property					0
Issuance of limited partnership units in exchange for real estate properties					$ 0

Nature of Operations

Nature of Operations	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Corix Bioscience, Inc. (“we”, “our”, “Corix”, the “Company”), formerly American Housing Income Trust, Inc. was incorporated on December 17, 2007 under the laws of the State of Nevada. On February 13, 2015, following the acquisition of the majority and controlling shares of the Company by American Realty Partners, LLC (“ARP”), a change of control of the Company took place. On May 11, 2015, the Company converted into a Maryland corporation and changed its name to American Housing Income Trust, Inc. On May 15, 2017, the Company converted into a Wyoming corporation and changed its name to Corix Bioscience, Inc. On August 3, 2015, the Company, and Valfre Holdings, LLC, an Arizona limited liability company, and James A. Valfre and Pamela J. Valfre, f/k/a Pruitt (collectively, "Valfre") closed on the Company's acquisition of nine single family residences in Arizona through an umbrella limited liability partnership organized in Maryland called "AHIT Valfre, LLP" (“AHIT Valfre”). Pursuant to the AHIT Valfre Agreements, in consideration for the conveyance of the nine single family residences, which were acquired by AHIT Valfre “subject to” existing mortgages, AHIT Valfre issued limited partnership interests to Valfre. On April 8, 2016, AHIT Valfre completed its internal restructuring and the partners in AHIT Valfre restructured their respective interests in the partnership resulting in AHIT Valfre GP, LLC (“AHIT Valfre GP”) and AHIT Valfre Limiteds, LLC (“AHIT Valfre Limiteds”) serving as General Partner and Limited Partner respectively, of AHIT Valfre. On August 10, 2016, the Company, and Northern New Mexico Properties, LLC, a New Mexico limited liability company closed on the Company’s acquisition of six single family residences, four apartments and sixteen mobile homes spaces located in New Mexico through an umbrella limited liability partnership organized in Maryland called “AHIT Northern NM Properties, LLP” (“AHIT NNMP”). Pursuant to the AHIT NNMP Agreements, in consideration for the conveyance of the six single family residences, four apartments and sixteen mobile homes spaces, which were acquired by AHIT NNMP “subject to” existing mortgages, AHIT NNMP issued limited partnership interests to Northern New Mexico Properties, LLC. On March 1, 2017, the Company entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”), a company focused on the production of certified organic cannabidol oil (“CBD”). The transaction closed on April 6, 2017 and, pursuant to the agreement, the Company issued 10,000,000 shares of its restricted common stock in exchange for all the issued and outstanding shares of IXB. As a result of the Stock Exchange Agreement the Company will become IXB’s sole shareholder, making IXB a subsidiary of the Company. In conjunction with the closing of the Stock Exchange Agreement, the Company has restructured its Board of Directors. On March 13, 2017, the Board of Directors adopted the Company’s Second Amended Bylaws, forming the Real Estate Committee (the “Committee”). The Committee will be charged with managing all business-related matters regarding the Company’s real estate holdings. On March 21, 2017, the Board of Directors of the Company terminated the offering set forth in the registration statement on Form S-11 and related prospectus, which had been deemed effective on June 23, 2016, and a subsequent post-effective amendment deemed effective on September 19, 2016. On April 1, 2017, the Company amended the Limited Liability Partnership Agreement of AHIT-NNMP dated July 13, 2016. Pursuant to the amendment, the limited partner may at its sole option, purchase from the Company its partnership interest for the sum of $35,000 commencing July 14, 2017. On July 14, 2017, the limited partner exercised its right and purchased from the Company the partnership interest. During the three months ended September 30, 2017, the Company dissolved the following wholly-owned subsidiaries following the disposition of the real estate properties and payment of outstanding financing liabilities: American Realty Partners, LLC, APR Borrower, LLC, APR Pledgor, LLC, APR Borrower II, LLC, ARP Pledgor II, LLC, AHIT-Valfre and AHIT Valfre GP, LLC. The Company is in the business of producing certified organic cannabidol oil. During the nine months ended September 30, 2017, the Company has discontinued the business of acquiring and operating residential properties and begun to dispose its residential properties. As of the date of this filing, the Company holds title to 5 residential properties and 1 commercial property.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	a) Basis of Presentation and Principles of Consolidation These unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US”) and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes for the years ended December 31, 2016 and 2015 contained in the Company’s Form 10-K filed on April 10, 2017. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown have been reflected herein. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the years ended December 31, 2016 and 2015 as reported in the Company’s Form 10-K have been omitted. These consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary IX Biotechnology, Inc. All significant intercompany transaction and balances have been eliminated. On June 24, 2015, the Company’s fiscal year-end changed from January 31 to December 31. On March 1, 2017, Corix entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”). The transaction closed on April 6, 2017 and, pursuant to the agreement, Corix issued 10,000,000 shares of common stock in exchange for all acquired IXB (See Note 4). The operations of Corix were significant in comparison to those of IXB so the consolidated financial statements are presented under predecessor reporting wherein the prior historical information consists of solely Corix’s results of operations and cash flows. The consolidated financial statements included herein are presented for the three and nine months ended September 30, 2017, and 2016, under predecessor entity reporting. The results of operations and cash flows obtained through the use of April 1, 2017, rather than April 6, 2017, are not considered to be materially different; therefore, the successor period is presented beginning April 1, 2017. b) Use of Estimates The preparation of financial statements in conformity with US generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, and income taxes. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. c) Fair Value of Financial Instruments The carrying amounts reported in the consolidated balance sheets for accounts payable and accrued liabilities, amounts due to/from related parties and notes payable are reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if, applicable, the stated rate of interest is equivalent to rates currently available. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company utilizes a three-level valuation hierarchy for disclosures of fair value measurements, defined as follows: Level 1 Financial assets and liabilities for which values are based on unadjusted quoted prices for identical assets or liabilities in an active market that management has the ability to access. Level 1 Financial assets and liabilities for which values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability (commodity derivatives and interest rate swaps). Level 1 Financial assets and liabilities for which values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company does not have any financial instruments that are required to be measured and recorded at fair value on a recurring basis. d) Non-controlling Interest Limited partnership units in AHIT NNMP that are not owned by the Company are presented as non-controlling interest in the equity section of our consolidated balance sheets. Our limited partners do not have the right to share in the net income or losses of AHIT NNMP but have the right to convert all or part of their partnership units to common shares of the Company on a one-for-one basis following the one-year anniversary of issuance. At the time of redemption, we have the right to determine whether to redeem the non-controlling limited partnership units of AHIT NNMP for cash, based upon the fair value of an equivalent number of shares of our common stock at the time of redemption. On April 1, 2017, the Company amended the Limited Liability Partnership Agreement of AHIT-NNMP dated July 13, 2016. Pursuant to the amendment, the limited partner may at its sole option, purchase from the Company its partnership interest for the sum of $35,000 commencing July 14, 2017. On July 14, 2017, the limited partner exercised its right and purchased from the Company its partnership interest. e) Reclassification Certain reclassifications have been made to conform previously reported data to the current presentation. These reclassifications have no effect on our net income (loss) or financial position as previously reported. f) Recent Accounting Pronouncements In August 2015, FASB issued ASU 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date”. The amendments in ASU 2015-14 defer the effective date of ASU 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This ASU is based on the principle that entities should recognize assets and liabilities arising from leases. The ASU does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The ASU’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term on operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting under the ASC is largely unchanged from the previous accounting standard. In addition, the ASU expands the disclosure requirements of lease arrangements. Lessees and lessors will use a modified retrospective transition approach, which includes a number of practical expedients. The effective date will be the first quarter of fiscal year 2019 with early adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-02 will have on the Company’s financial statements adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-02 will have on the Company’s financial statements In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)”. The amendments in this ASU are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations by amending certain existing illustrative examples and adding additional illustrative examples to assist in the application of the guidance. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation, Improvements to Employee Share-Based Payment Accounting (Topic 718). This update is intended to provide simplification of the accounting for share based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The effective date is the first quarter of fiscal year 2017 with early adoption permitted. The adoption of ASU 2016-09 did not have an impact on the Company’s financial statements. In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customer (Topic 606): Identifying Performance Obligations and Licensing.” The amendments in this ASU clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In May 2016, the FASB issued ASU 2016-12, “Revenue from Contracts with Customer (Topic 606): Narrow-Scope Improvements and Practical Expedients.” The amendments in this ASU affect only the narrow aspects of Topic 606. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force). ASU 2016-15 reduces diversity in practice in how certain transactions are classified in the statement of cash flows. The effective date will be the first quarter of fiscal year 2018 with early adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-15 will have on the Company’s financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2017
Note 3 - Going Concern
Going Concern	These interim consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has never paid any dividends and is unlikely to pay dividends in the immediate or foreseeable future. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders, the ability of the Company to obtain necessary debt and equity financing to continue operations, and the attainment of profitable operations. During the six months ended September 30, 2017, the Company incurred a net loss of $5,298,536 s at September 30, 2017, the Company has accumulated losses of $5,298,536 since inception. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company has been successful in raising cash through equity offerings in the past. The Company has financing efforts in place to continue to raise cash through equity offerings. Management has developed a plan to continue operations. This plan includes obtaining equity and debt financing and reducing expenses. During the six months ended September 30, 2017, the Company received $438,000 net proceeds from debt financing. Although the Company has successfully completed financings in the past fiscal years, the Company cannot assure that the plans to address these matters in the future will be successful.

Reverse Acquisition

Reverse Acquisition	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Reverse Acquisition	On March 1, 2017, the Company entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”), a Wyoming corporation. The transaction closed on April 6, 2017 and, pursuant to the agreement, the Company issued 10,000,000 shares of its restricted common stock in exchange for all the issued and outstanding shares of IXB. As a result of the Stock Exchange Agreement the Company became IXB’s sole shareholder, making IXB a subsidiary of the Company. The transaction is accounted for as a reverse acquisition and IXB is considered the accounting acquirer for financial reporting purposes. Assets

Related party transactions

Related party transactions	9 Months Ended
	Sep. 30, 2017
Related Party Transactions [Abstract]
Related party transactions	a) American Realty Partners (“ARP”), the Company’s former subsidiary, has been advised and managed by Performance Realty Management, LLC (“PRM”), an Arizona limited liability company (the “Manager”). At the formation of ARP, ARP agreed to pay the Manager of ARP quarterly management fees equal to the greater of: (a) $120,000 on an annual basis, or (b) 1% of the total assets of ARP in consideration for the management services to be rendered to or on behalf of ARP by the Manager. Commencing January 1, 2016, PRM started to serve as the Manager of ARP at no cost. During the six months ended September 30, 2017, the Company discovered that $267,841 of improvement costs for a property owned by the Manager of ARP were erroneously capitalized by and paid by the Company during the fiscal years 2014 – 2016 ($52,000 in 2014, $201,932 in 2015 and $13,909 in 2016). The error was corrected during the six months ended September 30, 2017. Before the adjustment, ARP was indebted to the Manager of ARP for $164,275, which represents advances provided by the Manager of ARP for daily operations. The correction of the error resulted in a receivable from the Manager of APR in the amount of $103,566. As at December 31, 2016, ARP is indebted to the Manager of APR for $363,698, which represents advances provided by the Manager of ARP for daily operations. b) On May 15, 2015, the Company entered into an Advisory Board Consulting and Compensation Agreement with a former director of the Company pursuant to which the Company agreed to issue 1,000,000 shares of common stock to the former director. In addition, the Company agreed to pay the former director an annual fee equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. The 1,000,000 shares of AHIT were issued on July 6, 2015. On February 25, 2016, the Company amended the Advisory Board Consulting and Compensation Agreement and the director agreed to serve on the Board of Directors at no cost. c) On February 25, 2016, the Company entered into an employment agreement with the former CFO of the Company for a period of three years. The Company agreed to pay the former CFO an annual salary equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. On December 30, 2016, the Company amended the employment agreement and the former CFO of the Company agreed to serve as the CFO of the Company at no cost. The former CFO also agreed to waive his rights to the share issuance in favor of a reduced issuance of 616,180 shares of the Company’s common stock for the period of February 25, 2016 through October 7, 2016. On August 1, 2016, before the amendment, the Company issued 439,401 shares of common stock to PRM, pursuant to a Designation and Acceptance of Rights entered into between PRM, the Company, and the former CFO. The former CFO agreed to waive his rights to the issuance of the remaining 176,779 shares of common stock. d) On July 28, 2016, PRM was issued 439,401 shares of common stock in the Company pursuant to a Designation and Acceptance of Rights (the “Designation”) entered into between PRM, the Company, and the former CFO of the Company. On August 15, 2016, as part of a restructuring of related parties, PRM and the Company closed on a Stock Exchange and Restructuring Agreement (the “Exchange Agreement”). As a result of the closing of the Exchange Agreement, those prior members of PRM were issued shares of common stock in the Company. e) On August 31, 2017, the Company entered into an employment agreement with the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) of the Company for a period of three years. The Company agreed to pay the CEO an annual salary equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. During the six months ended September 30, 2017, the Company recorded management fees of $10,000 and stock based compensation of $8,333. As of September 30, 2017, the Company is indebted to the CEO of the Company for $10,000 (December 31, 2016 - $nil), which represents management fees owed to the CEO.

Convertible Debenture

Convertible Debenture	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Convertible Debenture	On April 4, 2017, the Company issued a 2% Convertible Note with a principal amount of $525,000 and warrants to purchase up to 787,500 shares of common stock at $0.50 per share, exercisable for a period of five years from issuance. Pursuant to the Note, the Company will receive total proceeds of $500,000 in tranches, net of a prorated 5% original issue discount (“OID”). Interest is calculated at 2% per annum and any principal or interest not paid when due will bear interest at 15% per annum, commencing the due date. The maturity date of each tranche is 6 months from the effective date of each payment. The Convertible Note is secured by the Company’s collateral. Any unpaid principal and interest can be converted into shares of common stock at a fixed conversion price of $0.50 per share. As at September 30, 2017, the Company has received total proceeds of $288,000, net of Original Discounts of $14,400 and debt financing fees of $12,000. On September 6, 2017, the Company repaid a total of $200,000. On April 10, 2017, the Company received proceeds of $188,000 net of an Original Discount of $10,000 and debt financing fees of $12,000. The fair value of the 315,000 Warrants on April 10, 2017 was $211,100, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $104,726 and $105,274, respectively. The effective conversion price was then determined to be $0.50. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the warrants of $105,274 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $104,726. The beneficial conversion feature of $82,726, the OID of $10,000 and the debt financing fees of $12,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability or beneficial conversion associated with the debenture under ASC 815-15 Derivatives and Hedging On May 9, 2017, the Company received proceeds of $100,000 net of an Original Discount of $5,000. The fair value of the 157,500 Warrants on May 9, 2017 was $111,789, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $50,856 and $54,144, respectively. The effective conversion price was then determined to be $0.50. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the warrants of $54,144 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $50,856. The beneficial conversion feature of $45,856 and the OID of $5,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability or beneficial conversion associated with the debenture under ASC 815-15 Derivatives and Hedging On July 3, 2017, the Company issued a 10% Convertible Note with a principal amount of $175,000 and warrants to purchase 218,750 shares of common stock at $0.40 per share, exercisable for a period of five years from issuance. Pursuant to the Note, the Company received proceeds of $150,000, net of original issue discount (“OID”) of $22,250 and debt financing cost of $2,750. Interest is calculated at 10% per annum and any principal or interest not paid when due will bear interest at 24% per annum, commencing the due date. The maturity date is 6 months from the effective date of each payment. All principal and accrued interest on the Note is convertible into shares of the Company’s common stock at the lesser of (i) the lowest trading price during the previous 25 trading days prior to the issuance of the note, and (ii) 50% multiplied by the lowest trading price during the 25 trading days prior to the conversion date. As at September 30, 2017, the Company has received proceeds of $150,000, net of Original Discounts of $22,250 and debt financing cost of $2,750. The Company determined that there was no derivative liability associated with the debenture under ASC 815-15 Derivatives and Hedging. The Company then evaluated whether the embedded conversion option within the debt instrument is beneficial to the holder. Since the market price at closing was greater than the conversion price, it was determined that there was a beneficial conversion feature. The fair value of the 218,750 warrants on July 3, 2017 was $206,285, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $80,320 and $94,680, respectively. The Company recognized the relative fair value of the warrants of $94,680 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $80,320. The beneficial conversion feature of $55,320, the OID of $22,250 and the debt financing cost of $2,750 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount and debt financing cost are being expensed over the term of the loan to increase the carrying value to the face value of the loan. During the nine months ended September 30, 2017, the Company recorded accretion of discount of $13,872 and debt financing costs of $221, increasing the carrying value of the loan to $14,093. As at September 30, 2017, the Company has recorded accrued interest of $4,267.

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Common Stock	a) On April 6, 2017, the Company issued 10,000,000 shares of common stock pursuant to the Share Exchange Agreement as disclosed in Note 4. b) On April 17, 2017, the Company issued 200,000 shares of common stock at a fair value of $138,000 pursuant to the consulting agreement as disclosed in Note 10(c). c) On June 2, 2017, the Company issued 225,000 shares of common stock upon the exercise of 225,000 options and received proceeds of $225. See Note 10(f). d) On July 7, 2017, the Company issued 200,000 shares of common stock upon the exercise of 200,000 options and received proceeds of $200. See Note 10(f). e) On August 4, 2017, the Company issued 100,000 shares of common stock upon the exercise of 100,000 options and received proceeds of $100. See Note 10(f). f) On September 1, 2017, the Company issued 100,000 shares of common stock upon the exercise of 100,000 options and received proceeds of $100. See Note 10(f). g) On September 15, 2017, the Company repurchased 50,289 shares of common stock at a purchase price of $3.10 per share pursuant to a redemption agreement as discussed in Note 10. h) On September 25, 2017, the Company issued 10,000 shares of common stock at a fair value of $11,300 pursuant to the consulting agreement as disclosed in Note 10(h). i) On September 29, 2017, the Company issued 50,000 shares of common stock upon the exercise of 50,000 options for proceeds of $50 of which $25 is receivable at September 30, 2017. See Note 10(f).

Stock Options

Stock Options	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options	On May 26, 2017, the Company issued 700,000 options to a consultant to purchase 700,000 shares of common stock of the Company at $0.001 per share. See Note 11(f). The options shall vest as follows: 450,000 options vest immediately upon issuance on May 26, 2017 and expire on July 7, 2017, 100,000 options shall vest on July 8, 2017 and expire on August 4, 2017, 100,000 options shall vest on August 5, 2017 and expire on September 1, 2017, 50,000 options shall vest on September 2, 2017 and expire on September 29, 2017, and 25,000 options shall vest on September 30, 2017 and expire on October 27, 2017. The following table summarizes information about the options for the six months ended September 30, 2017: Number of options Weighted average exercise price $ Options outstanding – March 31, 2017 – – Granted 700,000 0.001 Exercised (675,000) 0.001 Options outstanding – September 30, 2017 25,000 0.001 Options exercisable – September 30, 2017 25,000 0.001 The following table summarizes information about stock options outstanding and exercisable at September 30, 2017: Exercise Price Options Options Weighted average remaining contracted life $ outstanding Exercisable (years) 0.001 25,000* 25,000 0.07 * Exercised subsequently (Note 11). Share-based compensation expense is determined using the Black-Scholes Option Pricing Model. During the nine months ended September 30, 2017, the Company recognized share-based compensation expense of $450,801 in additional paid-in capital. The weighted average fair value of the options granted during the nine months ended September 30, 2017, was $0.64. Weighted average assumptions used in calculating the fair value of stock-based compensation expense are as follows: For the Nine Months Ended September 30, 2017 Risk-free rate 0.75% - 1.00% Dividend yield 0% Volatility factor of the expected market price of the Company's common shares 211% - 479% Weighted average expected life of the options (years) 0.08– 0.12

Share Purchase Warrants

Share Purchase Warrants	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Share Purchase Warrants	The following table summarizes information about the warrants issued: Number of warrants Weighted average exercise price $ Outstanding, March 31, 2017 – – Issued 691,250 0.47 Outstanding, September 30, 2017 691,250 0.47 The following table summarizes information about warrants outstanding as at September 30, 2017: Exercise price Expiry date Warrants outstanding September 30, 2017 $ 0.50 April 10, 2022 315,000 $ 0.50 May 9, 2022 157,500 $ 0.40 July 3, 2022 218,750

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments And Contingencies
Commitments and Contingencies	a) On May 15, 2015, American Realty Partners (“ARP”), a former subsidiary of the Company, entered into Parent-Subsidiary and Operations Agreement (“Subsidiary Agreement) with the Company and Performance Realty Management, LLC (“PRM”). Pursuant to the Subsidiary Agreement, the Company agreed to be bound by ARP’s Operating Agreement dated November 1, 2013. The Subsidiary Agreement was amended on June 29, 2015 to provide for the issuance of 1,000,000 post-split shares of the Company as consideration for services to be rendered by PRM upon written notice to the Company. On December 21, 2015, ARP amended its operating agreement with PRM wherein it ratified the issuance of the 1,000,000 post-split shares of restricted common stock as the sole compensation paid to PRM for serving as manager of ARP. b) On April 11, 2017, IXB entered into a consulting agreement with Black Legend Capital for consulting and financial advisory services for a period of six months. Pursuant to the agreement, the Company agreed to pay a compensation of $30,000 upon execution of the agreement. c) On April 17, 2017, the Company entered into a Consulting Agreement (“Agreement”) with International Monetary, Inc., a California corporation (“International Monetary”) for a period of six months. Pursuant to the Agreement, International Monetary will provide a variety of services to the Company, including, but not limited to, corporate and management services; financial services; shareholder relations and corporate communication services; business development services; investor relations coordination and services; and guidance to maximize shareholder value with a concentrated focus on assisting with specific corporate governance requirements for an up listing to a major listed exchange. In exchange for these services, the Company will issue to International Monetary restricted shares of common stock in an amount equal to two percent (2%) of the Company’s issued and outstanding common stock (the “Stock Compensation”). The Stock Compensation shall be made in two payments, one percent (1%) of the issued and outstanding stock as of April 17, 2017 shall be issued upon the execution of the Agreement, and the remaining one percent (1%) shall be issued ninety (90) days thereafter. In addition to the Stock Compensation, the Company will pay a monthly cash management fee of $5,000 per month (the “Management Fee”). On May 19, 2017, the Company issued 200,000 shares to International Monetary. d) On May 1, 2017, IXB entered into a service agreement with Segra Biogenesis Corp. (“Segra”) whereby Segra will design a cannabis tissue culture facility for IXB. In consideration of the services, IXB will pay to Segra CAD$25,461. e) On May 24, 2017, the Company entered into a lease agreement for premises located in Carson City, Nevada for hemp oil processing. The leases commences on August 1, 2017 and is for a term of three years ending July 31, 2020. From August 1, 2017 to July 31, 2017, the monthly base rent is $6,579.30. From August 1, 2018 to July 31, 2019, the monthly base rent is $6,776.68. From August 1, 2019 to July 31, 2020, the monthly base rent is $6,979.98. f) On May 26, 2017, the Company entered into a Consulting Agreement (“Agreement”) with Global Discovery Group (“Global”) for a period of six months. Pursuant to the Agreement, in exchange for consulting services, the Company will issue 700,000 options to the consultant to purchase 700,000 shares of common stock of the Company at $0.001 per share. The options shall vest as follows: 450,000 options vest immediately upon issuance on May 26, 2017 and expire on July 7, 2017, 100,000 options shall vest on July 8, 2017 and expire on August 4, 2017, 100,000 options shall vest on August 5, 2017 and expire on September 1, 2017, 50,000 options shall vest on September 2, 2017 and expire on September 29, 2017, and 25,000 options shall vest on September 30, 2017 and expire on October 27, 2017. g) On August 14, 2017, the Company entered into a Sales Agreement with Positively Green Organics, LLC (“PGO”), whereby PGO has agreed to farm cannabidol flower for the Company’s processing and sales to third-parties (the “Sales Agreement”). PGO has committed 150 acres of farming land for the manufacturing process. In addition to processing and sales, the Company will be providing ancillary support services to PGO as part of the overall farming and manufacturing process. PGO is to deliver 10% or more of cannabidol flower with less than .3% THC or cannabidol flower approved by the State of Nevada Department of Agriculture to the Company. In turn, the Company will process the cannabidol flower and sell all of the cannabidol flower biomass to third-parties. The Company will be capped at 22,000 pounds per month unless otherwise agreed to by the parties. The Company and PGO have agreed to a profit sharing relationship from the sales. h) On September 25, 2017, the Company entered into a Consulting agreement for corporate finance and consulting services for a period of 3 months. Pursuant to the agreement, the Company agreed to pay $10,000 and to issue 10,000 shares of the Company’s common stock per month. Litigation Other than the litigation identified herein, the Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company, which if determined unfavorably to the Company, would have a material adverse effect on the Company's consolidated financial position, consolidated results of operations, or consolidated cash flows. a) The Company is a defendant in a civil matter pending in Maricopa county, Arizona brought by a current shareholder – Raymond and Winnie Yule. The plaintiff was a member in American Realty prior to the Share Exchange Agreement with the Company was effectuated. The plaintiff alleges that American Realty promised a particular real estate investment strategy and were assured a certain rate of return. The plaintiff alleges that American Realty failed in these matters and seeks for damages. On September 15, 2017, to settle the case, the Company sold 8 properties and redeemed 50,289 shares of common stock from Raymond and Winnie Yule. The Company recorded a loss on settlement of $740,756 during the six months ended September 30, 2017. b) There have been allegations of fraud made against the CEO of the Company by William Bills, Joaquin Flores and George Elam, all of whom are shareholders in the company as a result of the Stock Exchange Agreement as described in Note 4. Our counsel has conducted investigations into the matter, and has concluded that there is no merit to the allegations and that such allegations have been asserted as an attempt to either extort money out of the company or additional stock. Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its consolidated balance sheets, consolidated statements of operations, or consolidated cash flows. Additionally, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that management believes would require additional disclosure or the recording of a loss contingency. Other Matters The Company, due to the nature of its relationship with PRM, has been the subject of an investigation by the State of Idaho. The specific focus of the investigation is on PRM. The State of Arizona’s Corporation Commission, Securities Division issued a letter and subpoena for formal interview on March 21, 2017. The specific focus of the investigation is not clear at this time.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Management has evaluated subsequent events up to and including November 20, 2017, which is the date the statements were available for issuance and determined there are no reportable subsequent events except the following: On October 3, 2017, the Company entered into a Purchase Agreement to purchase a 46,060 square foot building in Carson City, Nevada (the “Property”) by or before November 4, 2017. The building is intended to serve as the Company’s new research and development laboratory with an indoor grow facility specifically for its industrial hemp genetics – the core of the Company’s business. The purchase price for the facility is $1,300,000. At November 20, the Company has not closed this transaction. On October 16, 2017, the Company entered into an Investor Relations Agreement for a term of six months. The initial compensation was paid on October 16, 2017 with the payment of $5,000. In addition, the Company issued 360,000 shares of common stock on October 20, 2017. The Company also agreed to continue to pay $5,000 per month starting on November 16, 2017 and continuing until March 16, 2018 for a total of $30,000. On October 25, 2017, the Company issued 10,000 shares of common stock pursuant to the consulting agreement as discussed in Note 11(h). On October 27, 2017, the Company issued 25,000 shares of common stock upon the exercise of 25,000 options. See Note 11(f). On November 1, 2017, the Company entered into three consulting agreements for a term of six months. Pursuant to the agreements, the Company agreed to issue 700,000 shares of common stock to each consultant. 1,400,000 of the 2,100,000 shares were issued on November 8, 2017. The remaining 700,000 shares have not been issued as at November 9, 2017.(might need to update before filing) On November 1, 2017, the Company and David Lamont Manaway and Juhuru Holdings, Ltd. (collectively, the “Selling Shareholders”), closed on their Agreement for Sale of Shares of Pharmaceutical Development Company (Pty), Ltd., a company incorporated under the laws of the Kingdom of Lesotho (“PDC”). The transaction had been approved by the Board of Directors on October 30, 2017. In consideration for the issuance of 1,300,000 shares of restricted common stock in the Company and $200,000, the Company acquired 1,000 shares of common stock from the Selling Shareholders resulting in PDC being a wholly-owned subsidiary of the Company. On November 1, 2017, the Company issued 1,300,000 shares to the Selling Shareholders. On November 6, 2017, the Company issued 1,000 shares of common stock as finders fees in connection with a stock subscription agreement. Subsequent to September 30, 2017, the Company sold 1 property for proceeds of $239,248. Subsequent to September 30, 2017, the Company issued 375,000 shares for proceeds of $306,000. Subsequent to September 30, 2017, the Company repaid $220,000 to Firstfire.(needs explanation from Michael on how the Company arrived at a repayment of $220,000 when the outstanding balance was only $115,000).

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	On April 6, 2017, the Company completed a reverse acquisition (Note 4) and changed the focus of the business as the Company is no longer pursuing to be a REIT. The assets and liabilities related to the REIT business have been presented as held for discontinued operations following the approval of management to sell the assets and liabilities. i. Current assets of disposal group classified as held for discontinued operations 2017 $ 2016 $ Accounts receivable 310 2,406 Other assets 16,892 209,1520 Due from related party 103,566 – Total 120,768 211,558 ii. Non-current assets of disposal group classified as held for discontinued operations 2017 $ 2016 $ Land 1,663,713 6,736,848 Building and improvements, net 687,415 4,390,398 Loan receivable – related party 242,979 – Total 2,594,107 11,127,246 iii. Current liabilities of disposal group classified as held for discontinued operations 2017 $ 2016 $ Accounts payable and accrued liabilities 38,411 119,291 Due to related parties 136 7,164 Note payable – related parties – 74,307 Prepaid rent received 1,780 13,048 Note payable 6,870 386,656 Total 47,197 600,466 iv. Non-current liabilities of disposal group classified as held for discontinued operations 2017 $ 2016 $ Note payable 652,836 4,690,077 Total 652,836 4,690,077 Analysis of the result of discontinued operations, and the result on the re-measurement of assets is as follows: For the Three Months Ended September 30, 2017 $ For the Three Months Ended September 30, 2016 $ April 6, 2017 through September 30, 2017 $ January 1, 2017 through April 6, 2017 $ For the Nine Months Ended September 30, 2016 $ Successor Predecessor Successor Predecessor Predecessor Revenue 44,496 175,695 192,782 170,819 503,210 Expenses Depreciation 25,767 43,864 56,772 43,269 109,259 General and administrative 728,346 1,261,364 1,266,236 421,434 3,498,539 Interest expense 35,385 91,038 102,617 78,371 286,526 Total expenses 789,498 1,396,266 1,425,625 543,074 3,894,324 Net loss before other income (expenses) from discontinued operations (745,002 ) (1,220,571 ) (1,232,843 ) (372,255 ) (3,391,114 ) Interest Income 1,389 — 1,389 — — (Loss) gain on sale of properties (661,672 ) — (728,839 ) 269,521 4,981 Impairment of real estate properties (149,860 ) — (277,762 ) (37,071 ) — Loss from disposal of subsidiary (1,066,426 ) — (1,066,426 ) — — Net loss from discontinued operations (2,621,571 ) (1,220,571 ) (3,304,481 ) (139,805 ) (3,386,133 ) Cash flows: For the Six Months Ended September 30, 2017 For the Three Months Ended March 31, 2017 For the Nine Months Ended September 30, 2016 Successor Predecessor Predecessor Operating activities Net loss from discontinued operations (3,304,481 ) (139,805 ) (3,386,133 ) Items not affecting cash: Depreciation 56,772 43,269 109,260 Loss (gain) on sale of assets 728,839 (269,521 ) (4,981 ) Impairment of real estate properties 277,762 37,071 — Stock-based compensation — — 1,950,794 Write-off of accounts receivable — 1,950 — Loss on disposal of subsidiary 1,066,426 — — Imputed Interest (1,389 ) — — Changes in operating assets and liabilities: Accounts receivable (5,030 ) (5,826 ) (6,188 ) Prepaid expenses 148,870 40,145 (39,566 ) Accounts payable (45,783 ) (2,130 ) 21,785 Accrued liabilities (42,830 ) 20,357 31,575 Prepaid rent received (12,214 ) 946 (15,760 ) Due to related parties 1,792 18,330 16,905 Net cash used in operating activities – discontinued operations (1,131,266 ) (255,214 ) (1,322,309 ) Investing activities Purchase of real estate properties and improvements (11,005 ) (3,592 ) (22,908 ) Proceeds from sale of real estate properties, net 3,258,951 384,996 211,200 Proceeds from sale of subsidiary 22,651 — — Net cash provided by investing activities – discontinued operations 3,270,597 381,404 188,292 Financing activities Advances received from related party 5,000 — — Proceeds from notes payable — — 325,232 Repayment of related party note payable (1,478 ) (1,685 ) — Repayment of notes payable (1,232,208 ) (19,742 ) (52,327 ) Repayment of related party advances (61,402 ) — — Net cash (used in) provided by investing activities – discontinued operations (1,290,088 ) (21,427 ) 272,905 Note receivable On September 20, 2017, the Company sold a property to PRM, the manager of a former subsidiary of the Company for a note receivable in the amount of $325,000. The note is non-interest bearing, due on October 1, 2022 and secured by the property sold to PRM. Pursuant to ASC 835-30, the Company determined the present value of the note by discounting the note at an imputed interest rate of 6.07%, resulting in a carrying value of $241,590 at issuance. The resulting discount of $83,410 is to be recognized as interest income over the term of the note. As at September 30, 2017, the Company has recognized interest income of $1,389 and the carrying value of the note was increased to $242,979. Investment in Real Estate September 30, 2017 December 31, 2016 Cost of real estate properties $ 2,606,760 $ 11,603,385 Accumulated depreciation (93,263) (354,639) Impairment of real estate properties (162,369) (121,500) Balance at the end of the period $ 2,351,128 $ 11,127,246 During the six months ended September 30, 2017, the Company sold 34 properties for gross proceeds of $5,638,395 and a note receivable in the amount $325,000 and recognized a loss on sale of $728,839. Of the $5,638,395 proceeds, $2,381,411 was used to settle debt associated with the properties. During the three months ended June 30, 2017, the Company discovered that $267,841 of improvement costs for a property owned by the Manager of ARP were erroneously capitalized by and paid by the Company during the fiscal years 2014 – 2016 ($52,000 in 2014, $201,932 in 2015 and $13,909 in 2016). $65,909 of the $267,841 capitalized cost was related to a property the predecessor sold during the 3 months ended March 31, 2017. $186,932 of the $267,841 capitalized cost was related to another property that remains a property of the Company as at June 30, 2017. The error was corrected during the three months ended June 30, 2017 and the $247,841 capitalized during fiscal year 2014-2016 and $15,000 of depreciation expense were reversed. As one of the properties was already sold, the Company recorded a gain of $65,909 on sale of asset. During the three months ended March 31, 2017, the predecessor recorded depreciation expense of $43,269 for its real estate properties. During the six months ended September 30, 2017, the Company recorded depreciation expense of $56,772 for its real estate properties. During the nine months ended September 30, 2016, the predecessor recorded depreciation expense of $109,260 for its real estate properties. During the three months ended March 31, 2017, the predecessor recorded impairment of $37,071 for its real estate properties. During the six months ended September 30, 2017, the Company recorded impairment of $277,762 for its real estate properties. During the nine months ended September 30, 2016, no impairment was recorded for its real estate properties by the predecessor. Prepaid Rent Received September 30, 2017 December 31, 2016 Balance, beginning of period $ 13,994 $ 39,598 Prepaid rent recognized as revenue during the period (73,903) (160,559) Prepaid rent received during the period 61,689 134,009 Balance, end of period $ 1,780 $ 13,048 Related Party Transactions a) On July 13, 2016, the Company entered into the Master UPREIT Formation Agreement resulting in the formation of AHIT NNMP, LLP, a Maryland limited liability company. Pursuant to the agreement, the Company agreed to retain the designee of the Limited Partner to serve as property manager during the period from the closing of the transaction to the exercise of the conversion option. In consideration for the property management services, the Limited Partner or its designee shall receive a property management fee equal to a mutually agreeable yearly fee based on a good faith analysis of net profits from the operation of the partnership for the year, but under no circumstances in excess of $120,000. b) As of June 30, 2017, the Company is indebted to the former limited partner of AHIT Valfre, LLP for $136 (December 31, 2016 - $136), of repair expenses the limited partner paid on behalf of the Company. c) On July 15, 2016, the Company entered into a Consultancy Agreement with the Vice President of the Company for consulting services. The Consultancy Agreement is for a term of one year. In addition to a $30,000 signing bonus, the Company has agreed to issue 25,000 restricted shares as compensation and bi-weekly monetary compensation that is on par with the value of the services provided by the Vice President. On July 20, 2016, the Company issued the 25,000 shares of common stock with a fair value of $75,000 to the Vice President of the Company. d) On July 15, 2016, the Company entered into a Board Director Agreement whereby the Company has agreed to issue 10,000 restricted shares of common stock as compensation. In addition to the 10,000 shares of common stock, the Company has agreed to pay the Director from time to time monetary and equity compensation for the services. As at September 30, 2017, the Company has not issued the 10,000 shares. e) On July 21, 2016, the Company entered into a Board Director Agreement whereby the Company has agreed to issue 10,000 restricted shares of common stock as compensation. In addition to the 10,000 shares of common stock, the Company has agreed to pay the Director from time to time monetary and equity compensation for the services. On October 31, 2016, the Company issued the 10,000 shares of common stock with a fair value of $30,000. f) On July 14, 2017, the limited partner of AHIT NNMP purchased from the Company its General Partnership interest in AHIT NNMP for $35,000. As a result, the net assets of AHIT-NNMP of $1,101,426 was derecognized and a loss on sale of subsidiary of $1,066,426 was recognized. g) On September 20, 2017, the Company sold one property to PRM, the manager of a former subsidiary of the Company for a $325,000 note receivable. The note is non-interest bearing and secured by the property sold to PRM and due on October 1, 2022. h) During the three months ended March 31, 2017, the predecessor paid commission of $31,575 to a company owned by the former CFO of the predecessor. During the six months ended September 30, 2017, the Company paid commission of $129,185 to a company owned by the director of the Company. i) American Realty Partners (“ARP”), the Company’s former subsidiary, has been advised and managed by Performance Realty Management, LLC (“PRM”), an Arizona limited liability company (the “Manager”). At the formation of ARP, ARP agreed to pay the Manager of ARP quarterly management fees equal to the greater of: (a) $120,000 on an annual basis, or (b) 1% of the total assets of ARP in consideration for the management services to be rendered to or on behalf of ARP by the Manager. Commencing January 1, 2016, PRM started to serve as the Manager of ARP at no cost. During the six months ended September 30, 2017, the Company discovered that $267,841 of improvement costs for a property owned by the Manager of ARP were erroneously capitalized by and paid by the Company during the fiscal years 2014 – 2016 ($52,000 in 2014, $201,932 in 2015 and $13,909 in 2016). The error was corrected during the six months ended September 30, 2017. Before the adjustment, ARP was indebted to the Manager of ARP for $164,275, which represents advances provided by the Manager of ARP for daily operations. The correction of the error resulted in a receivable from the Manager of APR in the amount of $103,566. As at December 31, 2016, ARP is indebted to the Manager of APR for $363,698, which represents advances provided by the Manager of ARP for daily operations j) As of September 30, 2017, the Company is indebted to the former CFO of the Company, and three companies owned by the former CFO of the Company, for $nil (December 31, 2016 - $44,030), which represents advances made to the Company by the former CFO and the three companies owned by the former CFO. Notes Payable September 30, 2017 $ December 31, 2016 $ Mortgage payable on February 20, 2034, bearing interest at a variable rate, collateralized by a deed of trust on the real estate property purchased with the loan 68,893 194,984 Promissory note payable on November 1, 2019, bearing interest at 5.371% per annum, collateralized by the real estate properties titled to ARP Borrower, LLC and 100% equity ownership in ARP Borrower, LLC. The note is also secured by the Company – 1,628,276 Promissory note payable on December 1, 2020, bearing interest at 5.88% per annum, collateralized by the real estate properties titled to ARP Borrower II, LLC and 100% equity ownership in ARP Borrower II, LLC – 956,815 Promissory note payable on May 27, 2017, bearing interest at 16% per annum, collateralized by a deed of trust on the real estate property purchased with the loan – 180,000 Promissory note payable on July 8, 2017, bearing interest at 18% per annum initially and at 12% per annum after four months, collateralized by a deed of trust on the real estate property purchased with the loan – 80,000 Promissory note payable on October 1, 2017, bearing interest at 16% per annum, collateralized by a deed of trust on the real estate properties titled to ARP – 122,298 Promissory note payable on January 1, 2022, bearing interest at 10% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan 350,000 350,000 Mortgage payable on April 1, 2053, bearing interest at 2% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan 240,813 244,767 Promissory note payable on May 1, 2021, bearing interest at 6.07% per annum, collateralized by the real estate properties titled to AHIT Valfre, LLP and ARP Borrower, LLC – 1,196,022 Mortgage payable on April 1, 2028, bearing interest at 2.985% per annum, collateralized by the real estate property purchased with the loan – 123,571 659,706 5,076,733 Note payable – related party, payable on June 1, 2026, bearing interest at 4.5% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan – 74,307 659,706 5,151,040 Less: Current Portion of Note payable (6,870) 652,836 The following table schedules the principal payments on the notes payable for the next five years and thereafter as of September 30, 2017: Year Amount 2017 $ 1,504 2018 7,180 2019 7,379 2020 7,583 2021 7,793 thereafter 628,267 Total $ 659,706 Single Family Residence Acquisitions As of September 30, 2017, the Company owns 6 residential properties and 1 commercial property. The estimated useful life of the buildings and improvements related to these assets is 27 years. The following table sets forth the metropolitan statistical area, metropolitan division, number of homes, aggregate net investment, and average investment for each home acquired. MSA / Metro Division Number of Homes Aggregate Investment Average Investment per Home Arizona 2 $ 591,041 $ 295,521 California 3 1,767,323 589,108 Texas 2 248,396 124,198 Total and Weighted Average 7 $ 2,606,760 $ 372,394 The Company computes depreciation using the straight-line method over the estimated useful lives of 27 years for building cost. The Company makes this determination based on subjective assessments as to the useful lives of the Company’s properties for purposes of determining the amount of depreciation to record on an annual basis with respect to our investments in single family real estate. Employment Agreements On April 15, 2016, the Company entered into employment agreements with two individuals for a term of one year. The Company agreed to issue an aggregate of 200,000 restricted shares as compensation and weekly monetary compensation that is on par with the value of the services provided by the consultants. On July 20, 2016 and July 26, 2016, the Company issued an aggregate of 200,000 shares to the consultants. On July 15, 2016, the Company entered into an employment agreement with the Vice President of the Company for a term of one year. The Company agreed to issue 25,000 restricted shares as compensation and bi-weekly monetary compensation that is on par with the value of the services provided by the Vice President of the Company. In addition, the Company agreed to pay the Vice President a signing bonus of $30,000. On July 20, 2016, the Company issued 25,000 shares to the Vice President of the Company. On December 8, 2016, the Company entered into an employment agreement with its Property Manager for an initial term of six months (“Probation Period”). During the Probation Period, the compensation is to be determined solely by the Company exercising its sole discretion. Following the Probation Period, the Company shall pay the Property Manager compensation equal to 5% of gross rental income from the Company’s tenants. Lease Agreements The Company rents properties under non-cancellable lease agreements with a term of one year. Future minimum rental revenues under leases existing on our properties at September 30, 2017 through the end of their term, are as follows: Fiscal Year 2017 $ 5,835 Fiscal Year 2018 3,120 Total $ 8,955

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	These unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US”) and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes for the years ended December 31, 2016 and 2015 contained in the Company’s Form 10-K filed on April 10, 2017. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown have been reflected herein. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the years ended December 31, 2016 and 2015 as reported in the Company’s Form 10-K have been omitted. These consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary IX Biotechnology, Inc. All significant intercompany transaction and balances have been eliminated. On June 24, 2015, the Company’s fiscal year-end changed from January 31 to December 31. On March 1, 2017, Corix entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”). The transaction closed on April 6, 2017 and, pursuant to the agreement, Corix issued 10,000,000 shares of common stock in exchange for all acquired IXB (See Note 4). The operations of Corix were significant in comparison to those of IXB so the consolidated financial statements are presented under predecessor reporting wherein the prior historical information consists of solely Corix’s results of operations and cash flows. The consolidated financial statements included herein are presented for the three and nine months ended September 30, 2017, and 2016, under predecessor entity reporting. The results of operations and cash flows obtained through the use of April 1, 2017, rather than April 6, 2017, are not considered to be materially different; therefore, the successor period is presented beginning April 1, 2017.
Use of Estimates	The preparation of financial statements in conformity with US generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, and income taxes. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Fair Value of Financial Instruments	The carrying amounts reported in the consolidated balance sheets for accounts payable and accrued liabilities, amounts due to/from related parties and notes payable are reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if, applicable, the stated rate of interest is equivalent to rates currently available. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company utilizes a three-level valuation hierarchy for disclosures of fair value measurements, defined as follows: Level 1 Financial assets and liabilities for which values are based on unadjusted quoted prices for identical assets or liabilities in an active market that management has the ability to access. Level 1 Financial assets and liabilities for which values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability (commodity derivatives and interest rate swaps). Level 1 Financial assets and liabilities for which values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company does not have any financial instruments that are required to be measured and recorded at fair value on a recurring basis.
Non-controlling Interest	Limited partnership units in AHIT NNMP that are not owned by the Company are presented as non-controlling interest in the equity section of our consolidated balance sheets. Our limited partners do not have the right to share in the net income or losses of AHIT NNMP but have the right to convert all or part of their partnership units to common shares of the Company on a one-for-one basis following the one-year anniversary of issuance. At the time of redemption, we have the right to determine whether to redeem the non-controlling limited partnership units of AHIT NNMP for cash, based upon the fair value of an equivalent number of shares of our common stock at the time of redemption. On April 1, 2017, the Company amended the Limited Liability Partnership Agreement of AHIT-NNMP dated July 13, 2016. Pursuant to the amendment, the limited partner may at its sole option, purchase from the Company its partnership interest for the sum of $35,000 commencing July 14, 2017. On July 14, 2017, the limited partner exercised its right and purchased from the Company its partnership interest.
Reclassification	Certain reclassifications have been made to conform previously reported data to the current presentation. These reclassifications have no effect on our net income (loss) or financial position as previously reported.
Recent Accounting Pronouncements	In August 2015, FASB issued ASU 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date”. The amendments in ASU 2015-14 defer the effective date of ASU 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This ASU is based on the principle that entities should recognize assets and liabilities arising from leases. The ASU does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The ASU’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term on operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting under the ASC is largely unchanged from the previous accounting standard. In addition, the ASU expands the disclosure requirements of lease arrangements. Lessees and lessors will use a modified retrospective transition approach, which includes a number of practical expedients. The effective date will be the first quarter of fiscal year 2019 with early adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-02 will have on the Company’s financial statements adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-02 will have on the Company’s financial statements In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)”. The amendments in this ASU are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations by amending certain existing illustrative examples and adding additional illustrative examples to assist in the application of the guidance. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation, Improvements to Employee Share-Based Payment Accounting (Topic 718). This update is intended to provide simplification of the accounting for share based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The effective date is the first quarter of fiscal year 2017 with early adoption permitted. The adoption of ASU 2016-09 did not have an impact on the Company’s financial statements. In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customer (Topic 606): Identifying Performance Obligations and Licensing.” The amendments in this ASU clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In May 2016, the FASB issued ASU 2016-12, “Revenue from Contracts with Customer (Topic 606): Narrow-Scope Improvements and Practical Expedients.” The amendments in this ASU affect only the narrow aspects of Topic 606. The effective date and transition of these amendments is the same as the effective date and transition of ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. Public entities should apply the amendments in ASU 2014-09 for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently in the process of evaluating the impact of the adoption on its financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force). ASU 2016-15 reduces diversity in practice in how certain transactions are classified in the statement of cash flows. The effective date will be the first quarter of fiscal year 2018 with early adoption permitted. Management continues to assess the overall impact the adoption of ASU 2016-15 will have on the Company’s financial statements. The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Stock Options (Tables)

Stock Options (Tables)	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of stock option activities	Number of options Weighted average exercise price $ Options outstanding – March 31, 2017 – – Granted 700,000 0.001 Exercised (675,000) 0.001 Options outstanding – September 30, 2017 25,000 0.001 Options exercisable – September 30, 2017 25,000 0.001
Schedule of stock options outstanding	Exercise Price Options Options Weighted average remaining contracted life $ outstanding Exercisable (years) 0.001 25,000* 25,000 0.07
Schedule of stock options valuation assumptions	For the Nine Months Ended September 30, 2017 Risk-free rate 0.75% - 1.00% Dividend yield 0% Volatility factor of the expected market price of the Company's common shares 211% - 479% Weighted average expected life of the options (years) 0.08– 0.12

Share Purchase Warrants (Tables

Share Purchase Warrants (Tables)	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Schedule of Warrants, Activity	Number of warrants Weighted average exercise price $ Outstanding, March 31, 2017 – – Issued 691,250 0.47 Outstanding, September 30, 2017 691,250 0.47
Schedule of Outstanding Warrants	Exercise price Expiry date Warrants outstanding September 30, 2017 $ 0.50 April 10, 2022 315,000 $ 0.50 May 9, 2022 157,500 $ 0.40 July 3, 2022 218,750

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Schedule of discontinued operations activity	i. Current assets of disposal group classified as held for discontinued operations 2017 $ 2016 $ Accounts receivable 310 2,406 Other assets 16,892 209,1520 Due from related party 103,566 – Total 120,768 211,558 ii. Non-current assets of disposal group classified as held for discontinued operations 2017 $ 2016 $ Land 1,663,713 6,736,848 Building and improvements, net 687,415 4,390,398 Loan receivable – related party 242,979 – Total 2,594,107 11,127,246 iii. Current liabilities of disposal group classified as held for discontinued operations 2017 $ 2016 $ Accounts payable and accrued liabilities 38,411 119,291 Due to related parties 136 7,164 Note payable – related parties – 74,307 Prepaid rent received 1,780 13,048 Note payable 6,870 386,656 Total 47,197 600,466 iv. Non-current liabilities of disposal group classified as held for discontinued operations 2017 $ 2016 $ Note payable 652,836 4,690,077 Total 652,836 4,690,077 Analysis of the result of discontinued operations, and the result on the re-measurement of assets is as follows: For the Three Months Ended September 30, 2017 $ For the Three Months Ended September 30, 2016 $ April 6, 2017 through September 30, 2017 $ January 1, 2017 through April 6, 2017 $ For the Nine Months Ended September 30, 2016 $ Successor Predecessor Successor Predecessor Predecessor Revenue 44,496 175,695 192,782 170,819 503,210 Expenses Depreciation 25,767 43,864 56,772 43,269 109,259 General and administrative 728,346 1,261,364 1,266,236 421,434 3,498,539 Interest expense 35,385 91,038 102,617 78,371 286,526 Total expenses 789,498 1,396,266 1,425,625 543,074 3,894,324 Net loss before other income (expenses) from discontinued operations (745,002 ) (1,220,571 ) (1,232,843 ) (372,255 ) (3,391,114 ) Interest Income 1,389 — 1,389 — — (Loss) gain on sale of properties (661,672 ) — (728,839 ) 269,521 4,981 Impairment of real estate properties (149,860 ) — (277,762 ) (37,071 ) — Loss from disposal of subsidiary (1,066,426 ) — (1,066,426 ) — — Net loss from discontinued operations (2,621,571 ) (1,220,571 ) (3,304,481 ) (139,805 ) (3,386,133 ) Cash flows: For the Six Months Ended September 30, 2017 For the Three Months Ended March 31, 2017 For the Nine Months Ended September 30, 2016 Successor Predecessor Predecessor Operating activities Net loss from discontinued operations (3,304,481 ) (139,805 ) (3,386,133 ) Items not affecting cash: Depreciation 56,772 43,269 109,260 Loss (gain) on sale of assets 728,839 (269,521 ) (4,981 ) Impairment of real estate properties 277,762 37,071 — Stock-based compensation — — 1,950,794 Write-off of accounts receivable — 1,950 — Loss on disposal of subsidiary 1,066,426 — — Imputed Interest (1,389 ) — — Changes in operating assets and liabilities: Accounts receivable (5,030 ) (5,826 ) (6,188 ) Prepaid expenses 148,870 40,145 (39,566 ) Accounts payable (45,783 ) (2,130 ) 21,785 Accrued liabilities (42,830 ) 20,357 31,575 Prepaid rent received (12,214 ) 946 (15,760 ) Due to related parties 1,792 18,330 16,905 Net cash used in operating activities – discontinued operations (1,131,266 ) (255,214 ) (1,322,309 ) Investing activities Purchase of real estate properties and improvements (11,005 ) (3,592 ) (22,908 ) Proceeds from sale of real estate properties, net 3,258,951 384,996 211,200 Proceeds from sale of subsidiary 22,651 — — Net cash provided by investing activities – discontinued operations 3,270,597 381,404 188,292 Financing activities Advances received from related party 5,000 — — Proceeds from notes payable — — 325,232 Repayment of related party note payable (1,478 ) (1,685 ) — Repayment of notes payable (1,232,208 ) (19,742 ) (52,327 ) Repayment of related party advances (61,402 ) — — Net cash (used in) provided by investing activities – discontinued operations (1,290,088 ) (21,427 ) 272,905
Schedule of Investment in Real Estate	September 30, 2017 December 31, 2016 Cost of real estate properties $ 2,606,760 $ 11,603,385 Accumulated depreciation (93,263) (354,639) Impairment of real estate properties (162,369) (121,500) Balance at the end of the period $ 2,351,128 $ 11,127,246
Schedule of Prepaid Rent	September 30, 2017 December 31, 2016 Balance, beginning of period $ 13,994 $ 39,598 Prepaid rent recognized as revenue during the period (73,903) (160,559) Prepaid rent received during the period 61,689 134,009 Balance, end of period $ 1,780 $ 13,048
Note Schedule	September 30, 2017 $ December 31, 2016 $ Mortgage payable on February 20, 2034, bearing interest at a variable rate, collateralized by a deed of trust on the real estate property purchased with the loan 68,893 194,984 Promissory note payable on November 1, 2019, bearing interest at 5.371% per annum, collateralized by the real estate properties titled to ARP Borrower, LLC and 100% equity ownership in ARP Borrower, LLC. The note is also secured by the Company – 1,628,276 Promissory note payable on December 1, 2020, bearing interest at 5.88% per annum, collateralized by the real estate properties titled to ARP Borrower II, LLC and 100% equity ownership in ARP Borrower II, LLC – 956,815 Promissory note payable on May 27, 2017, bearing interest at 16% per annum, collateralized by a deed of trust on the real estate property purchased with the loan – 180,000 Promissory note payable on July 8, 2017, bearing interest at 18% per annum initially and at 12% per annum after four months, collateralized by a deed of trust on the real estate property purchased with the loan – 80,000 Promissory note payable on October 1, 2017, bearing interest at 16% per annum, collateralized by a deed of trust on the real estate properties titled to ARP – 122,298 Promissory note payable on January 1, 2022, bearing interest at 10% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan 350,000 350,000 Mortgage payable on April 1, 2053, bearing interest at 2% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan 240,813 244,767 Promissory note payable on May 1, 2021, bearing interest at 6.07% per annum, collateralized by the real estate properties titled to AHIT Valfre, LLP and ARP Borrower, LLC – 1,196,022 Mortgage payable on April 1, 2028, bearing interest at 2.985% per annum, collateralized by the real estate property purchased with the loan – 123,571 659,706 5,076,733 Note payable – related party, payable on June 1, 2026, bearing interest at 4.5% per annum, collateralized by a deed of trust on the real estate properties purchased with the loan – 74,307 659,706 5,151,040 Less: Current Portion of Note payable (6,870) 652,836
Schedule of Principal Payments	Year Amount 2017 $ 1,504 2018 7,180 2019 7,379 2020 7,583 2021 7,793 thereafter 628,267 Total $ 659,706
Average Investment by Geographic Location	MSA / Metro Division Number of Homes Aggregate Investment Average Investment per Home Arizona 2 $ 591,041 $ 295,521 California 3 1,767,323 589,108 Texas 2 248,396 124,198 Total and Weighted Average 7 $ 2,606,760 $ 372,394
Future minimum rental revenues under leases	Fiscal Year 2017 $ 5,835 Fiscal Year 2018 3,120 Total $ 8,955

Nature of Operations (Details N

Nature of Operations (Details Narrative)	9 Months Ended
	Sep. 30, 2017
Additional Information, Umbrella limited liability partnerships	During the three months ended September 30, 2017, the Company dissolved the following wholly-owned subsidiaries following the disposition of the real estate properties and payment of outstanding financing liabilities: American Realty Partners, LLC, APR Borrower, LLC, APR Pledgor, LLC, APR Borrower II, LLC, ARP Pledgor II, LLC, AHIT-Valfre and AHIT Valfre GP, LLC.
AHIT [Member]
Date of Incorporation	May 11, 2015
State of Incorporation	State of Maryland
Date of Name Change	May 11, 2015
CXBS [Member]
Date of Incorporation	May 15, 2017
State of Incorporation	State of Wyoming
Date of Name Change	May 15, 2017
IX Biotechnology, Inc. [Member]
Additional Information, Umbrella limited liability partnerships	On March 1, 2017, the Company entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”), a company focused on the production of certified organic cannabidol oil (“CBD”). The transaction closed on April 6, 2017 and, pursuant to the agreement, the Company issued 10,000,000 shares of its restricted common stock in exchange for all the issued and outstanding shares of IXB. As a result of the Stock Exchange Agreement the Company will become IXB’s sole shareholder, making IXB a subsidiary of the Company. In conjunction with the closing of the Stock Exchange Agreement, the Company has restructured its Board of Directors.
ATITValfreMember
Additional Information, Umbrella limited liability partnerships	On August 3, 2015, the Company, and Valfre Holdings, LLC, an Arizona limited liability company, and James A. Valfre and Pamela J. Valfre, f/k/a Pruitt (collectively, "Valfre") closed on the Company's acquisition of nine single family residences in Arizona through an umbrella limited liability partnership organized in Maryland called "AHIT Valfre, LLP" (“AHIT Valfre”). Pursuant to the AHIT Valfre Agreements, in consideration for the conveyance of the nine single family residences, which were acquired by AHIT Valfre “subject to” existing mortgages, AHIT Valfre issued limited partnership interests to Valfre. On April 8, 2016, AHIT Valfre completed its internal restructuring and the partners in AHIT Valfre restructured their respective interests in the partnership resulting in AHIT Valfre GP, LLC (“AHIT Valfre GP”) and AHIT Valfre Limiteds, LLC (“AHIT Valfre Limiteds”) serving as General Partner and Limited Partner respectively, of AHIT Valfre.
AHIT-NNMP [Member]
Additional Information, Umbrella limited liability partnerships	On August 10, 2016, the Company, and Northern New Mexico Properties, LLC, a New Mexico limited liability company closed on the Company’s acquisition of six single family residences, four apartments and sixteen mobile homes spaces located in New Mexico through an umbrella limited liability partnership organized in Maryland called “AHIT Northern NM Properties, LLP” (“AHIT NNMP”). Pursuant to the AHIT NNMP Agreements, in consideration for the conveyance of the six single family residences, four apartments and sixteen mobile homes spaces, which were acquired by AHIT NNMP “subject to” existing mortgages, AHIT NNMP issued limited partnership interests to Northern New Mexico Properties, LLC.
Green Bikes Rental Corp [Member]
Date of Incorporation	Dec. 17, 2007
State of Incorporation	State of Nevada

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Details Narrative)	Sep. 30, 2017USD ($)
AHIT-NNMP [Member]
Partnership interest	$ 35,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	6 Months Ended	23 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern, Net Income Loss	$ (5,298,536)	$ (5,298,536)
Net Proceeds, debt Financing	$ 438,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	9 Months Ended
	Sep. 30, 2017
Advisory Board Consulting Agreement [Member]
Related Party Transactions, Description of Transactions	On May 15, 2015, the Company entered into an Advisory Board Consulting and Compensation Agreement with a former director of the Company pursuant to which the Company agreed to issue 1,000,000 shares of common stock to the former director. In addition, the Company agreed to pay the former director an annual fee equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. The 1,000,000 shares of AHIT were issued on July 6, 2015. On February 25, 2016, the Company amended the Advisory Board Consulting and Compensation Agreement and the director agreed to serve on the Board of Directors at no cost.
Employment Agreement with Form CFO [Member]
Related Party Transactions, Description of Transactions	On February 25, 2016, the Company entered into an employment agreement with the former CFO of the Company for a period of three years. The Company agreed to pay the former CFO an annual salary equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. On December 30, 2016, the Company amended the employment agreement and the former CFO of the Company agreed to serve as the CFO of the Company at no cost. The former CFO also agreed to waive his rights to the share issuance in favor of a reduced issuance of 616,180 shares of the Company’s common stock for the period of February 25, 2016 through October 7, 2016. On August 1, 2016, before the amendment, the Company issued 439,401 shares of common stock to PRM, pursuant to a Designation and Acceptance of Rights entered into between PRM, the Company, and the former CFO. The former CFO agreed to waive his rights to the issuance of the remaining 176,779 shares of common stock.
Designation and Acceptance of Rights [Member]
Related Party Transactions, Description of Transactions	On July 28, 2016, PRM was issued 439,401 shares of common stock in the Company pursuant to a Designation and Acceptance of Rights (the “Designation”) entered into between PRM, the Company, and the former CFO of the Company. On August 15, 2016, as part of a restructuring of related parties, PRM and the Company closed on a Stock Exchange and Restructuring Agreement (the “Exchange Agreement”). As a result of the closing of the Exchange Agreement, those prior members of PRM were issued shares of common stock in the Company.
Indebted to Former CFO [Member]
Related Party Transactions, Description of Transactions	On August 31, 2017, the Company entered into an employment agreement with the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) of the Company for a period of three years. The Company agreed to pay the CEO an annual salary equal to $120,000 or 1% of the Company’s assets as reported on its year-end balance sheet, whichever is greater. The Company will also issue an aggregate of 3,000,000 shares of common stock of the Company on the first, second and third anniversary. During the six months ended September 30, 2017, the Company recorded management fees of $10,000 and stock based compensation of $8,333. As of September 30, 2017, the Company is indebted to the CEO of the Company for $10,000 (December 31, 2016 - $nil), which represents management fees owed to the CEO.
ARP and PRM [Member]
Related Party Transactions, Description of Transactions	American Realty Partners (“ARP”), the Company’s former subsidiary, has been advised and managed by Performance Realty Management, LLC (“PRM”), an Arizona limited liability company (the “Manager”). At the formation of ARP, ARP agreed to pay the Manager of ARP quarterly management fees equal to the greater of: (a) $120,000 on an annual basis, or (b) 1% of the total assets of ARP in consideration for the management services to be rendered to or on behalf of ARP by the Manager. Commencing January 1, 2016, PRM started to serve as the Manager of ARP at no cost. During the six months ended September 30, 2017, the Company discovered that $267,841 of improvement costs for a property owned by the Manager of ARP were erroneously capitalized by and paid by the Company during the fiscal years 2014 – 2016 ($52,000 in 2014, $201,932 in 2015 and $13,909 in 2016). The error was corrected during the six months ended September 30, 2017. Before the adjustment, ARP was indebted to the Manager of ARP for $164,275, which represents advances provided by the Manager of ARP for daily operations. The correction of the error resulted in a receivable from the Manager of APR in the amount of $103,566. As at December 31, 2016, ARP is indebted to the Manager of APR for $363,698, which represents advances provided by the Manager of ARP for daily operations.

Convertible Debenture (Details

Convertible Debenture (Details Narratives)	9 Months Ended
	Sep. 30, 2017USD ($)
Convertible Debt Two[Member]
Convertible Debenture, Description	On May 9, 2017, the Company received proceeds of $100,000 net of an Original Discount of $5,000. The fair value of the 157,500 Warrants on May 9, 2017 was $111,789, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $50,856 and $54,144, respectively. The effective conversion price was then determined to be $0.50. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the warrants of $54,144 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $50,856. The beneficial conversion feature of $45,856 and the OID of $5,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability or beneficial conversion associated with the debenture under ASC 815-15 Derivatives and Hedging
Accretion of discount	$ 29,591
Debt instrument carrying amount	29,591
Accrued interest	$ 828
Convertible Debt [Member]
Convertible Debenture, Description	On April 4, 2017, the Company issued a 2% Convertible Note with a principal amount of $525,000 and warrants to purchase up to 787,500 shares of common stock at $0.50 per share, exercisable for a period of five years from issuance. Pursuant to the Note, the Company will receive total proceeds of $500,000 in tranches, net of a prorated 5% original issue discount (“OID”). Interest is calculated at 2% per annum and any principal or interest not paid when due will bear interest at 15% per annum, commencing the due date. The maturity date of each tranche is 6 months from the effective date of each payment. The Convertible Note is secured by the Company’s collateral. Any unpaid principal and interest can be converted into shares of common stock at a fixed conversion price of $0.50 per share.
Proceeds from convertible Debt	$ 288,000
Debt Discount	14,400
Debt financing fees	12,000
Repayment of convertible debt	$ 200,000
Convertible Debt Three [Member]
Convertible Debenture, Description	On July 3, 2017, the Company issued a 10% Convertible Note with a principal amount of $175,000 and warrants to purchase 218,750 shares of common stock at $0.40 per share, exercisable for a period of five years from issuance. Pursuant to the Note, the Company received proceeds of $150,000, net of original issue discount (“OID”) of $22,250 and debt financing cost of $2,750. Interest is calculated at 10% per annum and any principal or interest not paid when due will bear interest at 24% per annum, commencing the due date. The maturity date is 6 months from the effective date of each payment. All principal and accrued interest on the Note is convertible into shares of the Company’s common stock at the lesser of (i) the lowest trading price during the previous 25 trading days prior to the issuance of the note, and (ii) 50% multiplied by the lowest trading price during the 25 trading days prior to the conversion date.
Proceeds from convertible Debt	$ 150,000
Debt Discount	22,250
Debt financing fees	$ 2,750
Convertible Debt Four [Member]
Convertible Debenture, Description	The Company determined that there was no derivative liability associated with the debenture under ASC 815-15 Derivatives and Hedging. The Company then evaluated whether the embedded conversion option within the debt instrument is beneficial to the holder. Since the market price at closing was greater than the conversion price, it was determined that there was a beneficial conversion feature. The fair value of the 218,750 warrants on July 3, 2017 was $206,285, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $80,320 and $94,680, respectively. The Company recognized the relative fair value of the warrants of $94,680 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $80,320. The beneficial conversion feature of $55,320, the OID of $22,250 and the debt financing cost of $2,750 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount and debt financing cost are being expensed over the term of the loan to increase the carrying value to the face value of the loan.
Debt financing fees	$ 221
Accretion of discount	13,872
Debt instrument carrying amount	14,093
Accrued interest	$ 4,267
Convertible Debt One [Member]
Convertible Debenture, Description	On April 10, 2017, the Company received proceeds of $188,000 net of an Original Discount of $10,000 and debt financing fees of $12,000. The fair value of the 315,000 Warrants on April 10, 2017 was $211,100, determined using Black-Scholes. As a result, the relative fair values of the convertible note and the warrants was $104,726 and $105,274, respectively. The effective conversion price was then determined to be $0.50. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the warrants of $105,274 as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $104,726. The beneficial conversion feature of $82,726, the OID of $10,000 and the debt financing fees of $12,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $nil. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability or beneficial conversion associated with the debenture under ASC 815-15 Derivatives and Hedging
Proceeds from convertible Debt	$ 188,000
Debt Discount	10,000
Debt financing fees	12,000
Repayment of convertible debt	200,000
Accretion of discount	206,342
Accrued interest	$ 876

Common Stock (Details Narrative

Common Stock (Details Narrative) - USD ($)	Sep. 01, 2017	Aug. 04, 2017	Jul. 07, 2017	Jun. 02, 2017	Sep. 29, 2017	Sep. 25, 2017	Apr. 17, 2017	Sep. 15, 2017	Apr. 06, 2017
Note 8 - Investment In Real Estate Details Narrative
Common stock, shares issued	100,000	100,000	200,000	225,000	50,000	10,000	200,000	50,289	10,000,000
Common stock, cash proceeds	$ 100	$ 100	$ 200	$ 225	$ 50	$ 11,300	$ 138,000
Common stock issued upon exercise of options	100,000	100,000	200,000	225,000	50,000

Stock Options - Option Activity

Stock Options - Option Activity (Details) - Employee Stock Options [Member]	6 Months Ended
	Sep. 30, 2017$ / sharesshares
Number of options
Number of options - beginning balance | shares	0
Number of options - granted | shares	700,000
Number of options - exercised | shares	(675,000)
Number of options - ending balance | shares	25,000
Number of options - Exercisable at the end | shares	25,000
Weighted Average Price Per Share
Weighted average price per share - beginning balance | $ / shares	$ 0
Weighted average price per share - granted | $ / shares	0.001
Weighted average price per share - exercised | $ / shares	0.001
Weighted average price per share - ending balance | $ / shares	0.001
Weighted Average Price Per Share exercisable at the end | $ / shares	$ 0.001

Stock Options - Options Outstan

Stock Options - Options Outstanding and Exercisable (Details) - Employee Stock Options [Member] - $ / shares		9 Months Ended
		Sep. 30, 2017	Mar. 31, 2017
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding		25,000	0
Options Exercisable		25,000
0.001 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price		$ 0.001
Options Outstanding	[1]	25,000
Options Exercisable		25,000
Options Outstanding Weighted Average Remaining Contractual Life (Years)		26 days
[1]	Exercised subsequently (Note 11).

Stock Options - Assumption (Det

Stock Options - Assumption (Details)	9 Months Ended
	Sep. 30, 2017
Dividend yield	0.00%
Maximum
Risk-free rate	1.00%
Volatility factor of the expected market price of the Company's common shares	479.00%
Weighted average expected life of the options (years)	1 month 13 days
Minimum
Risk-free rate	0.75%
Volatility factor of the expected market price of the Company's common shares	211.00%
Weighted average expected life of the options (years)	29 days

Stock Options (Details Narrativ

Stock Options (Details Narrative)	9 Months Ended
	Sep. 30, 2017USD ($)$ / shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options, Description	On May 26, 2017, the Company issued 700,000 options to a consultant to purchase 700,000 shares of common stock of the Company at $0.001 per share. See Note 11(f). The options shall vest as follows: 450,000 options vest immediately upon issuance on May 26, 2017 and expire on July 7, 2017, 100,000 options shall vest on July 8, 2017 and expire on August 4, 2017, 100,000 options shall vest on August 5, 2017 and expire on September 1, 2017, 50,000 options shall vest on September 2, 2017 and expire on September 29, 2017, and 25,000 options shall vest on September 30, 2017 and expire on October 27, 2017.
Share-based compensation expense using method	Black-Scholes Option Pricing Model
Share-based compensation expense | $	$ 450,801
Weighted average fair value of the options granted | $ / shares	$ 0.64

Share Purchase Warrants - Warra

Share Purchase Warrants - Warrants Issued (Details)	6 Months Ended
	Sep. 30, 2017$ / sharesshares
Notes to Financial Statements
Number of warrants - beginning balance | shares	0
Number of warrants - issued | shares	691,250
Number of warrants - ending balance | shares	691,250
Weighted average exercise price per warrant - beginning balance | $ / shares	$ 0
Weighted average exercise price per warrant - issued | $ / shares	0.47
Weighted average exercise price per warrant - ending balance | $ / shares	$ 0.47

Share Purchase Warrants - War33

Share Purchase Warrants - Warrants Outstanding (Details) - $ / shares	9 Months Ended
	Sep. 30, 2017	Mar. 31, 2017
Exercise Price	$ 0.47	$ 0
Warrants Outstanding, Number Outstanding	691,250	0
Warrant [Member] | $ 0.50
Exercise Price	$ 0.50
Expiry date	May 9, 2022
Warrants Outstanding, Number Outstanding	157,500
Warrant [Member] | $ 0.40
Exercise Price	$ 0.40
Expiry date	Jul. 3, 2022
Warrants Outstanding, Number Outstanding	218,750
Warrant [Member] | 0.50 [Member]
Exercise Price	$ 0.50
Expiry date	Apr. 10, 2022
Warrants Outstanding, Number Outstanding	315,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	9 Months Ended
	Sep. 30, 2017
Parent-Subsidiary and Operations Agreement [Member]
Commitments and Contingencies, Description	On May 15, 2015, American Realty Partners (“ARP”), a former subsidiary of the Company, entered into Parent-Subsidiary and Operations Agreement (“Subsidiary Agreement) with the Company and Performance Realty Management, LLC (“PRM”). Pursuant to the Subsidiary Agreement, the Company agreed to be bound by ARP’s Operating Agreement dated November 1, 2013. The Subsidiary Agreement was amended on June 29, 2015 to provide for the issuance of 1,000,000 post-split shares of the Company as consideration for services to be rendered by PRM upon written notice to the Company. On December 21, 2015, ARP amended its operating agreement with PRM wherein it ratified the issuance of the 1,000,000 post-split shares of restricted common stock as the sole compensation paid to PRM for serving as manager of ARP.
Employment Agreements [Member]
Commitments and Contingencies, Description	On April 15, 2016, the Company entered into employment agreements with two individuals for a term of one year. The Company agreed to issue an aggregate of 200,000 restricted shares as compensation and weekly monetary compensation that is on par with the value of the services provided by the consultants. On July 20, 2016 and July 26, 2016, the Company issued an aggregate of 200,000 shares to the consultants. On July 15, 2016, the Company entered into an employment agreement with the Vice President of the Company for a term of one year. The Company agreed to issue 25,000 restricted shares as compensation and bi-weekly monetary compensation that is on par with the value of the services provided by the Vice President of the Company. In addition, the Company agreed to pay the Vice President a signing bonus of $30,000. On July 20, 2016, the Company issued 25,000 shares to the Vice President of the Company. On December 8, 2016, the Company entered into an employment agreement with its Property Manager for an initial term of six months (“Probation Period”). During the Probation Period, the compensation is to be determined solely by the Company exercising its sole discretion. Following the Probation Period, the Company shall pay the Property Manager compensation equal to 5% of gross rental income from the Company’s tenants.
Pending Litigation [Member]
Commitments and Contingencies, Description	Litigation Other than the litigation identified herein, the Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company, which if determined unfavorably to the Company, would have a material adverse effect on the Company's consolidated financial position, consolidated results of operations, or consolidated cash flows. a) The Company is a defendant in a civil matter pending in Maricopa county, Arizona brought by a current shareholder – Raymond and Winnie Yule. The plaintiff was a member in American Realty prior to the Share Exchange Agreement with the Company was effectuated. The plaintiff alleges that American Realty promised a particular real estate investment strategy and were assured a certain rate of return. The plaintiff alleges that American Realty failed in these matters and seeks for damages. On September 15, 2017, to settle the case, the Company sold 8 properties and redeemed 50,289 shares of common stock from Raymond and Winnie Yule. The Company recorded a loss on settlement of $740,756 during the six months ended September 30, 2017. b) There have been allegations of fraud made against the CEO of the Company by William Bills, Joaquin Flores and George Elam, all of whom are shareholders in the company as a result of the Stock Exchange Agreement as described in Note 4. Our counsel has conducted investigations into the matter, and has concluded that there is no merit to the allegations and that such allegations have been asserted as an attempt to either extort money out of the company or additional stock.
Environmental Issue [Member]
Commitments and Contingencies, Description	Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its consolidated balance sheets, consolidated statements of operations, or consolidated cash flows. Additionally, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that management believes would require additional disclosure or the recording of a loss contingency.
Other [Member]
Commitments and Contingencies, Description	Other Matters The Company, due to the nature of its relationship with PRM, has been the subject of an investigation by the State of Idaho. The specific focus of the investigation is on PRM. The State of Arizona’s Corporation Commission, Securities Division issued a letter and subpoena for formal interview on March 21, 2017. The specific focus of the investigation is not clear at this time.
Consulting Agreement Two [Member]
Commitments and Contingencies, Description	On April 11, 2017, IXB entered into a consulting agreement with Black Legend Capital for consulting and financial advisory services for a period of six months. Pursuant to the agreement, the Company agreed to pay a compensation of $30,000 upon execution of the agreement.
Consulting Agreement One
Commitments and Contingencies, Description	On April 17, 2017, the Company entered into a Consulting Agreement (“Agreement”) with International Monetary, Inc., a California corporation (“International Monetary”) for a period of six months. Pursuant to the Agreement, International Monetary will provide a variety of services to the Company, including, but not limited to, corporate and management services; financial services; shareholder relations and corporate communication services; business development services; investor relations coordination and services; and guidance to maximize shareholder value with a concentrated focus on assisting with specific corporate governance requirements for an up listing to a major listed exchange. In exchange for these services, the Company will issue to International Monetary restricted shares of common stock in an amount equal to two percent (2%) of the Company’s issued and outstanding common stock (the “Stock Compensation”). The Stock Compensation shall be made in two payments, one percent (1%) of the issued and outstanding stock as of April 17, 2017 shall be issued upon the execution of the Agreement, and the remaining one percent (1%) shall be issued ninety (90) days thereafter. In addition to the Stock Compensation, the Company will pay a monthly cash management fee of $5,000 per month (the “Management Fee”). On May 19, 2017, the Company issued 200,000 shares to International Monetary.
Service Agreement [Member]
Commitments and Contingencies, Description	On May 1, 2017, IXB entered into a service agreement with Segra Biogenesis Corp. (“Segra”) whereby Segra will design a cannabis tissue culture facility for IXB. In consideration of the services, IXB will pay to Segra CAD$25,461.
Lease agreement [Member]
Commitments and Contingencies, Description	On May 24, 2017, the Company entered into a lease agreement for premises located in Carson City, Nevada for hemp oil processing. The leases commences on August 1, 2017 and is for a term of three years ending July 31, 2020. From August 1, 2017 to July 31, 2017, the monthly base rent is $6,579.30. From August 1, 2018 to July 31, 2019, the monthly base rent is $6,776.68. From August 1, 2019 to July 31, 2020, the monthly base rent is $6,979.98.
Consulting Agreement [Member]
Commitments and Contingencies, Description	On May 26, 2017, the Company entered into a Consulting Agreement (“Agreement”) with Global Discovery Group (“Global”) for a period of six months. Pursuant to the Agreement, in exchange for consulting services, the Company will issue 700,000 options to the consultant to purchase 700,000 shares of common stock of the Company at $0.001 per share. The options shall vest as follows: 450,000 options vest immediately upon issuance on May 26, 2017 and expire on July 7, 2017, 100,000 options shall vest on July 8, 2017 and expire on August 4, 2017, 100,000 options shall vest on August 5, 2017 and expire on September 1, 2017, 50,000 options shall vest on September 2, 2017 and expire on September 29, 2017, and 25,000 options shall vest on September 30, 2017 and expire on October 27, 2017.
Sales Agreement [Member]
Commitments and Contingencies, Description	On August 14, 2017, the Company entered into a Sales Agreement with Positively Green Organics, LLC (“PGO”), whereby PGO has agreed to farm cannabidol flower for the Company’s processing and sales to third-parties (the “Sales Agreement”). PGO has committed 150 acres of farming land for the manufacturing process. In addition to processing and sales, the Company will be providing ancillary support services to PGO as part of the overall farming and manufacturing process. PGO is to deliver 10% or more of cannabidol flower with less than .3% THC or cannabidol flower approved by the State of Nevada Department of Agriculture to the Company. In turn, the Company will process the cannabidol flower and sell all of the cannabidol flower biomass to third-parties. The Company will be capped at 22,000 pounds per month unless otherwise agreed to by the parties. The Company and PGO have agreed to a profit sharing relationship from the sales.
Consulting Agreement Four[Member]
Commitments and Contingencies, Description	On September 25, 2017, the Company entered into a Consulting agreement for corporate finance and consulting services for a period of 3 months. Pursuant to the agreement, the Company agreed to pay $10,000 and to issue 10,000 shares of the Company’s common stock per month.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	1 Months Ended
	Nov. 20, 2017
Subsequent Event [Member]
Subsequent Event Description	Management has evaluated subsequent events up to and including November 20, 2017, which is the date the statements were available for issuance and determined there are no reportable subsequent events except the following: On October 3, 2017, the Company entered into a Purchase Agreement to purchase a 46,060 square foot building in Carson City, Nevada (the “Property”) by or before November 4, 2017. The building is intended to serve as the Company’s new research and development laboratory with an indoor grow facility specifically for its industrial hemp genetics – the core of the Company’s business. The purchase price for the facility is $1,300,000. At November 20, the Company has not closed this transaction. On October 16, 2017, the Company entered into an Investor Relations Agreement for a term of six months. The initial compensation was paid on October 16, 2017 with the payment of $5,000. In addition, the Company issued 360,000 shares of common stock on October 20, 2017. The Company also agreed to continue to pay $5,000 per month starting on November 16, 2017 and continuing until March 16, 2018 for a total of $30,000. On October 25, 2017, the Company issued 10,000 shares of common stock pursuant to the consulting agreement as discussed in Note 11(h). On October 27, 2017, the Company issued 25,000 shares of common stock upon the exercise of 25,000 options. See Note 11(f). On November 1, 2017, the Company entered into three consulting agreements for a term of six months. Pursuant to the agreements, the Company agreed to issue 700,000 shares of common stock to each consultant. 1,400,000 of the 2,100,000 shares were issued on November 8, 2017. The remaining 700,000 shares have not been issued as at November 9, 2017.(might need to update before filing) On November 1, 2017, the Company and David Lamont Manaway and Juhuru Holdings, Ltd. (collectively, the “Selling Shareholders”), closed on their Agreement for Sale of Shares of Pharmaceutical Development Company (Pty), Ltd., a company incorporated under the laws of the Kingdom of Lesotho (“PDC”). The transaction had been approved by the Board of Directors on October 30, 2017. In consideration for the issuance of 1,300,000 shares of restricted common stock in the Company and $200,000, the Company acquired 1,000 shares of common stock from the Selling Shareholders resulting in PDC being a wholly-owned subsidiary of the Company. On November 1, 2017, the Company issued 1,300,000 shares to the Selling Shareholders. On November 6, 2017, the Company issued 1,000 shares of common stock as finders fees in connection with a stock subscription agreement. Subsequent to September 30, 2017, the Company sold 1 property for proceeds of $239,248. Subsequent to September 30, 2017, the Company issued 375,000 shares for proceeds of $306,000. Subsequent to September 30, 2017, the Company repaid $220,000 to Firstfire.(needs explanation from Michael on how the Company arrived at a repayment of $220,000 when the outstanding balance was only $115,000).

Discontinued Operations - Balan

Discontinued Operations - Balance Sheet (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Non-current assets of disposal group classified as held for discontinued operations
Building and improvements, net	$ 2,351,128	$ 11,127,246
Current liabilities of disposal group classified as held for discontinued operations
Note payable - related parties	0	74,307
Successor [Member]
Current assets of disposal group classified as held for discontinued operations
Accounts receivable	310
Other assets	16,892
Due from related party	103,566
Current assets of disposal group classified as held for discontinued operations	120,768
Non-current assets of disposal group classified as held for discontinued operations
Land	1,663,713
Building and improvements, net	687,415
Loan receivable – related party	242,979
Non-current assets of disposal group classified as held for discontinued operations	2,594,107
Current liabilities of disposal group classified as held for discontinued operations
Accounts payable and accrued liabilities	38,411
Due to related parties	136
Note payable - related parties	0
Prepaid rent received	1,780
Note payable	6,870
Current liabilities of disposal group classified as held for discontinued operations	47,197
Non-current liabilities of disposal group classified as held for discontinued operations
Note payable	652,836
Non-current liabilities of disposal group classified as held for discontinued operations	$ 652,836
Predecessor [Member]
Current assets of disposal group classified as held for discontinued operations
Accounts receivable		2,406
Other assets		209,152
Due from related party		0
Current assets of disposal group classified as held for discontinued operations		211,558
Non-current assets of disposal group classified as held for discontinued operations
Land		6,736,848
Building and improvements, net		4,390,398
Loan receivable – related party		0
Non-current assets of disposal group classified as held for discontinued operations		11,127,246
Current liabilities of disposal group classified as held for discontinued operations
Accounts payable and accrued liabilities		119,291
Due to related parties		7,164
Note payable - related parties		74,307
Prepaid rent received		13,048
Note payable		386,656
Current liabilities of disposal group classified as held for discontinued operations		600,466
Non-current liabilities of disposal group classified as held for discontinued operations
Note payable		4,690,077
Non-current liabilities of disposal group classified as held for discontinued operations		$ 4,690,077

Discontinued Operations - State

Discontinued Operations - Statements of Operations (Details) - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Apr. 06, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Expenses
Impairment of real estate properties							$ 162,369		$ 121,500
Predecessor [Member]
Revenue		$ 170,819		$ 175,695				$ 503,210
Expenses
Depreciation		43,269	$ 43,269	43,864				109,259
General and administrative		421,434		1,261,364				3,498,539
Interest expense		78,371		91,038				286,526
Total expenses		543,074		1,396,266				3,894,324
Net loss before other income (expenses) from discontinued operations		(372,255)		(1,220,571)				(3,391,114)
Interest Income		0		0				0
(Loss) gain on sale of properties		269,521		0				4,981
Impairment of real estate properties		(37,071)		0				0
Loss from disposal of subsidiary		0	$ 0	0				0
Net loss from discontinued operations		$ (139,805)		$ (1,220,571)				$ (3,386,133)
Successor [Member]
Revenue	$ 44,496				$ 192,782
Expenses
Depreciation	25,767				56,772	$ 56,772
General and administrative	728,346				1,266,236
Interest expense	35,385				102,617
Total expenses	789,498				1,425,625
Net loss before other income (expenses) from discontinued operations	(745,002)				(1,232,843)
Interest Income	1,389				1,389
(Loss) gain on sale of properties	(661,672)				(728,839)
Impairment of real estate properties	(149,860)				(277,762)
Loss from disposal of subsidiary	(1,066,426)				(1,066,426)	$ 1,066,426
Net loss from discontinued operations	$ (2,621,571)				$ (3,304,481)

Discontinued Operations - Cash

Discontinued Operations - Cash flows (Details) - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended
	Sep. 30, 2017	Apr. 06, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Predecessor [Member]
Operating activities
Net loss from discontinued operations			$ (139,805)				$ (3,386,133)
Items not affecting cash:
Depreciation		$ 43,269	43,269	$ 43,864			109,259
Loss (gain) on sale of assets			(269,521)				(4,981)
Impairment of real estate properties			37,071				0
Stock-based compensation			0				1,950,794
Write-off of accounts receivable			1,950				0
Loss on disposal of subsidiary		0	0	$ 0			0
Imputed Interest			0				0
Changes in operating assets and liabilities:
Accounts receivable			(5,826)				(6,188)
Prepaid expenses			40,145				(39,566)
Accounts payable			(2,130)				21,785
Accrued liabilities			20,357				31,575
Prepaid rent received			946				(15,760)
Due to related parties			18,330				16,905
Net cash used in operating activities - discontinued operations		(255,214)	(255,214)				(1,322,309)
Investing activities
Purchase of real estate properties and improvements			(3,592)				(22,908)
Proceeds from sale of real estate properties, net			384,996				211,200
Proceeds from sale of subsidiary			0				0
Net cash provided by investing activities – discontinued operations		381,404	381,404				188,292
Financing activities
Advances received from related party			0				0
Proceeds from notes payable			0				325,232
Repayment of related party note payable			(1,685)				0
Repayment of notes payable			(19,742)				(52,327)
Repayment of related party advances			0				0
Net cash (used in) provided by financing activities – discontinued operations		$ (21,427)	$ (21,427)				$ 272,905
Successor [Member]
Operating activities
Net loss from discontinued operations						$ (3,304,481)
Items not affecting cash:
Depreciation	$ 25,767				$ 56,772	56,772
Loss (gain) on sale of assets						728,839
Impairment of real estate properties						277,762
Stock-based compensation						0
Write-off of accounts receivable						0
Loss on disposal of subsidiary	$ (1,066,426)				(1,066,426)	1,066,426
Imputed Interest						(1,389)
Changes in operating assets and liabilities:
Accounts receivable						(5,030)
Prepaid expenses						148,870
Accounts payable						(45,783)
Accrued liabilities						(42,830)
Prepaid rent received						(12,214)
Due to related parties						1,792
Net cash used in operating activities - discontinued operations					(1,131,266)	(1,131,266)
Investing activities
Purchase of real estate properties and improvements						(11,005)
Proceeds from sale of real estate properties, net						3,258,951
Proceeds from sale of subsidiary						22,651
Net cash provided by investing activities – discontinued operations					3,270,597	3,270,597
Financing activities
Advances received from related party						5,000
Proceeds from notes payable						0
Repayment of related party note payable						(1,478)
Repayment of notes payable						(1,232,208)
Repayment of related party advances						(61,402)
Net cash (used in) provided by financing activities – discontinued operations					$ (1,290,088)	$ (1,290,088)

Discontinued Operations - Inves

Discontinued Operations - Investment in Real Estate - (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Banking and Thrift [Abstract]
Cost of real estate properties	$ 2,606,760	$ 11,603,385
Accumulated depreciation	(93,263)	(354,639)
Impairment of real estate properties	(162,369)	(121,500)
Balance at the end of the period	$ 2,351,128	$ 11,127,246

Discontinued Operations - Prepa

Discontinued Operations - Prepaid Rent Received (Details) - Prepaid Expenses And Other Current Assets [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Prepaid rent received, beginning of year	$ 13,994	$ 39,598
Prepaid rent recognized as revenue during the year	(73,903)	(160,559)
Prepaid rent received during the period	61,689	134,009
Prepaid rent received, end of the period	$ 1,780	$ 13,994

Discontinued Operations - Notes

Discontinued Operations - Notes Payable (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Note Payable	$ 659,706	$ 5,076,733
Note payable - related party	0	74,307
Note Payable	659,706	5,151,040
Less: Current Portion of Note payable	(6,870)
Note Payable non current	652,836
Promissory note payable one
Note Payable	0	956,815
Promissory note payable five
Note Payable	350,000	350,000
Mortgages payable
Note Payable	68,893	194,984
Promissory note payable four
Note Payable	0	122,298
Mortgages payable one
Note Payable	240,813	244,767
Promissory note payable three
Note Payable	0	80,000
Mortgages payable Two
Note Payable	0	123,571
Promissory note payable two
Note Payable	0	180,000
Promissory note payable
Note Payable	0	1,628,276
Promissory note payable six
Note Payable	$ 0	$ 1,196,022

Discontinued Operations - Sched

Discontinued Operations - Schedule of Principal Payments (Details)	Sep. 30, 2017USD ($)
Discontinued Operations and Disposal Groups [Abstract]
2,017	$ 1,504
2,018	7,180
2,019	7,379
2,020	7,583
2,021	7,793
Thereafter	628,267
Total	$ 659,706

Discontinued Operations - Singl

Discontinued Operations - Single Family Residence Acquisitions (Details)	Sep. 30, 2017USD ($)Properties
Number of Homes | Properties	7
Aggregate Investment	$ 2,606,760
Average Investment per Home	$ 372,394
Arizona [Member]
Number of Homes | Properties	2
Aggregate Investment	$ 591,041
Average Investment per Home	$ 295,521
California [Member]
Number of Homes | Properties	3
Aggregate Investment	$ 1,767,323
Average Investment per Home	$ 589,108
Texas [Member]
Number of Homes | Properties	2
Aggregate Investment	$ 248,396
Average Investment per Home	$ 124,198

Discontinued Operations - Futur

Discontinued Operations - Future minimum rental revenues under leases (Details)	Sep. 30, 2017USD ($)
Discontinued Operations and Disposal Groups [Abstract]
Fiscal Year 2017	$ 5,835
Fiscal Year 2018	3,120
Total	$ 8,955

Discontinued Operations (Detail

Discontinued Operations (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended
	Sep. 30, 2017	Apr. 06, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Proceeds from sale of real estate						$ 5,638,395
Note receivable						325,000
Loss on sale						728,839
Depreciation Expense						56,772	$ 109,260
Note receivable description							On September 20, 2017, the Company sold a property to PRM, the manager of a former subsidiary of the Company for a note receivable in the amount of $325,000. The note is non-interest bearing, due on October 1, 2022 and secured by the property sold to PRM. Pursuant to ASC 835-30, the Company determined the present value of the note by discounting the note at an imputed interest rate of 6.07%, resulting in a carrying value of $241,590 at issuance. The resulting discount of $83,410 is to be recognized as interest income over the term of the note. As at September 30, 2017, the Company has recognized interest income of $1,389 and the carrying value of the note was increased to $242,979.
Predecessor [Member]
Depreciation Expense		$ 1,279	$ 43,269	$ 382				$ 382
Impairment			$ 37,071					$ 0
Successor [Member]
Depreciation Expense	$ 2,094				$ 2,520
Impairment						$ 277,762
Sales Agreement [Member]
Commitments and Contingencies, Description							On August 14, 2017, the Company entered into a Sales Agreement with Positively Green Organics, LLC (“PGO”), whereby PGO has agreed to farm cannabidol flower for the Company’s processing and sales to third-parties (the “Sales Agreement”). PGO has committed 150 acres of farming land for the manufacturing process. In addition to processing and sales, the Company will be providing ancillary support services to PGO as part of the overall farming and manufacturing process. PGO is to deliver 10% or more of cannabidol flower with less than .3% THC or cannabidol flower approved by the State of Nevada Department of Agriculture to the Company. In turn, the Company will process the cannabidol flower and sell all of the cannabidol flower biomass to third-parties. The Company will be capped at 22,000 pounds per month unless otherwise agreed to by the parties. The Company and PGO have agreed to a profit sharing relationship from the sales.
Consulting Agreement [Member]
Commitments and Contingencies, Description							On May 26, 2017, the Company entered into a Consulting Agreement (“Agreement”) with Global Discovery Group (“Global”) for a period of six months. Pursuant to the Agreement, in exchange for consulting services, the Company will issue 700,000 options to the consultant to purchase 700,000 shares of common stock of the Company at $0.001 per share. The options shall vest as follows: 450,000 options vest immediately upon issuance on May 26, 2017 and expire on July 7, 2017, 100,000 options shall vest on July 8, 2017 and expire on August 4, 2017, 100,000 options shall vest on August 5, 2017 and expire on September 1, 2017, 50,000 options shall vest on September 2, 2017 and expire on September 29, 2017, and 25,000 options shall vest on September 30, 2017 and expire on October 27, 2017.
Parent-Subsidiary and Operations Agreement [Member]
Commitments and Contingencies, Description							On May 15, 2015, American Realty Partners (“ARP”), a former subsidiary of the Company, entered into Parent-Subsidiary and Operations Agreement (“Subsidiary Agreement) with the Company and Performance Realty Management, LLC (“PRM”). Pursuant to the Subsidiary Agreement, the Company agreed to be bound by ARP’s Operating Agreement dated November 1, 2013. The Subsidiary Agreement was amended on June 29, 2015 to provide for the issuance of 1,000,000 post-split shares of the Company as consideration for services to be rendered by PRM upon written notice to the Company. On December 21, 2015, ARP amended its operating agreement with PRM wherein it ratified the issuance of the 1,000,000 post-split shares of restricted common stock as the sole compensation paid to PRM for serving as manager of ARP.
Employment Agreements [Member]
Commitments and Contingencies, Description							On April 15, 2016, the Company entered into employment agreements with two individuals for a term of one year. The Company agreed to issue an aggregate of 200,000 restricted shares as compensation and weekly monetary compensation that is on par with the value of the services provided by the consultants. On July 20, 2016 and July 26, 2016, the Company issued an aggregate of 200,000 shares to the consultants. On July 15, 2016, the Company entered into an employment agreement with the Vice President of the Company for a term of one year. The Company agreed to issue 25,000 restricted shares as compensation and bi-weekly monetary compensation that is on par with the value of the services provided by the Vice President of the Company. In addition, the Company agreed to pay the Vice President a signing bonus of $30,000. On July 20, 2016, the Company issued 25,000 shares to the Vice President of the Company. On December 8, 2016, the Company entered into an employment agreement with its Property Manager for an initial term of six months (“Probation Period”). During the Probation Period, the compensation is to be determined solely by the Company exercising its sole discretion. Following the Probation Period, the Company shall pay the Property Manager compensation equal to 5% of gross rental income from the Company’s tenants.
Pending Litigation [Member]
Commitments and Contingencies, Description							Litigation Other than the litigation identified herein, the Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company, which if determined unfavorably to the Company, would have a material adverse effect on the Company's consolidated financial position, consolidated results of operations, or consolidated cash flows. a) The Company is a defendant in a civil matter pending in Maricopa county, Arizona brought by a current shareholder – Raymond and Winnie Yule. The plaintiff was a member in American Realty prior to the Share Exchange Agreement with the Company was effectuated. The plaintiff alleges that American Realty promised a particular real estate investment strategy and were assured a certain rate of return. The plaintiff alleges that American Realty failed in these matters and seeks for damages. On September 15, 2017, to settle the case, the Company sold 8 properties and redeemed 50,289 shares of common stock from Raymond and Winnie Yule. The Company recorded a loss on settlement of $740,756 during the six months ended September 30, 2017. b) There have been allegations of fraud made against the CEO of the Company by William Bills, Joaquin Flores and George Elam, all of whom are shareholders in the company as a result of the Stock Exchange Agreement as described in Note 4. Our counsel has conducted investigations into the matter, and has concluded that there is no merit to the allegations and that such allegations have been asserted as an attempt to either extort money out of the company or additional stock.
Environmental Issue [Member]
Commitments and Contingencies, Description							Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its consolidated balance sheets, consolidated statements of operations, or consolidated cash flows. Additionally, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that management believes would require additional disclosure or the recording of a loss contingency.
Other [Member]
Commitments and Contingencies, Description							Other Matters The Company, due to the nature of its relationship with PRM, has been the subject of an investigation by the State of Idaho. The specific focus of the investigation is on PRM. The State of Arizona’s Corporation Commission, Securities Division issued a letter and subpoena for formal interview on March 21, 2017. The specific focus of the investigation is not clear at this time.
Consulting Agreement Two [Member]
Commitments and Contingencies, Description							On April 11, 2017, IXB entered into a consulting agreement with Black Legend Capital for consulting and financial advisory services for a period of six months. Pursuant to the agreement, the Company agreed to pay a compensation of $30,000 upon execution of the agreement.
Consulting Agreement One
Commitments and Contingencies, Description							On April 17, 2017, the Company entered into a Consulting Agreement (“Agreement”) with International Monetary, Inc., a California corporation (“International Monetary”) for a period of six months. Pursuant to the Agreement, International Monetary will provide a variety of services to the Company, including, but not limited to, corporate and management services; financial services; shareholder relations and corporate communication services; business development services; investor relations coordination and services; and guidance to maximize shareholder value with a concentrated focus on assisting with specific corporate governance requirements for an up listing to a major listed exchange. In exchange for these services, the Company will issue to International Monetary restricted shares of common stock in an amount equal to two percent (2%) of the Company’s issued and outstanding common stock (the “Stock Compensation”). The Stock Compensation shall be made in two payments, one percent (1%) of the issued and outstanding stock as of April 17, 2017 shall be issued upon the execution of the Agreement, and the remaining one percent (1%) shall be issued ninety (90) days thereafter. In addition to the Stock Compensation, the Company will pay a monthly cash management fee of $5,000 per month (the “Management Fee”). On May 19, 2017, the Company issued 200,000 shares to International Monetary.
Service Agreement [Member]
Commitments and Contingencies, Description							On May 1, 2017, IXB entered into a service agreement with Segra Biogenesis Corp. (“Segra”) whereby Segra will design a cannabis tissue culture facility for IXB. In consideration of the services, IXB will pay to Segra CAD$25,461.
Lease agreement [Member]
Commitments and Contingencies, Description							On May 24, 2017, the Company entered into a lease agreement for premises located in Carson City, Nevada for hemp oil processing. The leases commences on August 1, 2017 and is for a term of three years ending July 31, 2020. From August 1, 2017 to July 31, 2017, the monthly base rent is $6,579.30. From August 1, 2018 to July 31, 2019, the monthly base rent is $6,776.68. From August 1, 2019 to July 31, 2020, the monthly base rent is $6,979.98.
Consulting Agreement Four[Member]
Commitments and Contingencies, Description							On September 25, 2017, the Company entered into a Consulting agreement for corporate finance and consulting services for a period of 3 months. Pursuant to the agreement, the Company agreed to pay $10,000 and to issue 10,000 shares of the Company’s common stock per month.
Pay off debt [Member]
Debt settlement							$ 2,381,411
Investment in Real Estate							During the three months ended June 30, 2017, the Company discovered that $267,841 of improvement costs for a property owned by the Manager of ARP were erroneously capitalized by and paid by the Company during the fiscal years 2014 – 2016 ($52,000 in 2014, $201,932 in 2015 and $13,909 in 2016). $65,909 of the $267,841 capitalized cost was related to a property the predecessor sold during the 3 months ended March 31, 2017. $186,932 of the $267,841 capitalized cost was related to another property that remains a property of the Company as at June 30, 2017. The error was corrected during the three months ended June 30, 2017 and the $247,841 capitalized during fiscal year 2014-2016 and $15,000 of depreciation expense were reversed. As one of the properties was already sold, the Company recorded a gain of $65,909 on sale of asset.